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1 INTRODUCTION 
1.1 Plant innate immunity  
All living organisms are continuously exposed to potential pathogens but the disease 
is the exception rather than the rule. The multicellular organisms are able to defend 
themselves against pathogen attack through the evolution of an immune system that is 
composed by two different systems: the innate immunity and the adaptive one. Innate 
immunity acts as the first line of defense against pathogen attack and, having an ancient 
origin, it is conserved among plant and animal kingdom. The adaptive immunity, also 
known as specific or acquired immunity, has evolved more recently. It exhibits a high 
specificity and is able to respond more vigorously to repeated exposure to the same 
pathogen (immunological memory). The main tools of this immune system are the 
antibodies. 
Plants, lacking the adaptive immune system, have developed an efficient array of 
preformed and inducible defenses to detect and block pathogen invasions. Constitutive 
defenses include the presence of preformed surface wax, cell wall, antimicrobial enzymes 
and secondary metabolites. During the evolution, pathogens have developed strategies to 
overcome preformed plant defenses but plants gained the ability to organize a sophisticated 
set of physical and chemical inducible defense mechanisms. These are activated by two 
distinct classes of pathogen elicitors: general (PAMPs) and specific elicitors (encoded by 
the avirulence genes of a given pathogen race). A simple but elegant view of plant 
pathogens interaction has been shown by Jones and Dangl (Jones JD and Dangl JL, 2006) 
in the zig zag model (Figure 1.1).  
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Figure1.1 Zig zag model. In phase 1 PAMPs or MAMPs (pathogen or microbial associated molecular 
pattern) are recognized by PRRs (pattern recognition receptors), resulting in PAMP-triggered immunity (PTI) 
that can stop further colonization. In phase 2, successful pathogens deploy effectors that contribute to 
pathogen virulence. Effectors can interfere with PTI and generate a effector-triggered susceptibility (ETS). In 
phase 3, a given effector is specifically recognized resulting in effector-triggered immunity (ETI). ETI is an 
amplified PTI response, resulting in disease resistance and usually in a hypersensitive cell death response 
(HR) at the infection site. In phase 4, natural selection drives pathogens to avoid ETI by shedding or 
diversifying the recognized effector gene or by acquiring additional effectors that suppress ETI.  
It is commonly accepted that PAMPs induce non host resistance by PRRs-mediated 
recognition whereas specific elicitors, able to overcome the PTI, induce a host resistance 
after recognition of the product of plant resistance genes (R genes). PTI (or non-host 
resistance) and ETI (or host resistance), induced by general and specific elicitors 
respectively, constitute two forms of innate immunity in plants. 
 
Figure 1.2 Innate immunity of plants and animals. The plant innate immunity (non host and host 
resistance) is compared to animal innate and adaptive immunity respectively (Iriti and Faoro 2007). 
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The plant defense responses, induced upon recognition of general or specific 
elicitors, are both physical and chemical, such as the deposition of callose (papilla) , the 
induction of hypersensitive response (HR) and antimicrobial proteins (AMPs) 
production. 
Antimicrobial proteins interfere with growth, differentiation, replication or diffusion 
of microorganisms. Furthermore, they share common biochemical features such as small 
dimension (5-10 KDa), high positive charge and high number of cysteines (4-6-8-10) in 
their primary sequences. During the last two decades many AMPs have been isolated in 
plants: NCBI database (http://www.ncbi.nlm.nih.gov) reports about 1500 proteins 
identifiable as plant antimicrobial peptides. A classification of AMPs is shown in 
PhytAMP database (Hammami R et al. 2009), the first database completely dedicated to 
plant antimicrobial peptides (Figure 1.3). Among these, the most studied antimicrobial 
peptide families are plant defensins, thionins, lipid transfer proteins, heveine-type proteins 
and snakins. 
 
Figure 1.3 Phylogenetic tree of plant AMPs. A multiple sequence alignment of 271 plant AMPs was used 
to produce a phylogenetic tree (Hammami R et al. 2009) . 
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1.2 Plant defensins 
Plant defensins are structurally and functionally related to defense peptides identified 
in several eukaryotic organisms, including mammals, birds, mollusks, insects and fungi. 
Phylogenetical analyses suggest that these peptides have a common ancestor and share 
common evolution steps. The presence of a defensin peptide in the myxobacteria 
Anaeromyxobacter dehalogenans supports the idea that they represent an ancient strategy 
of defense in prokaryotic life form, transferred to the eukaryotic lineage during the 
evolution (Carvalho AO and Gomes VM, 2009). 
Plant defensins are small (about 5-6 KDa), generally basic and cysteine-rich proteins. 
Typically the classical number of cysteine residues is eight but defensins with 10 cysteines 
have been identified in tobacco and petunia.  
First members of this family were isolated from the endosperm of  barley and wheat 
and they were originally called γ-thionins for their similar size and the same number of 
cysteines (Mendez E et al. 1990). The name “plant defensins” was coined later, when the 
identification of two new antifungal proteins from Raphanus sativus (Rs-AFP1 and Rs-
AFP2) permitted to notice that these proteins were more related to insect and mammal 
defensins than to the plant thionins (Terras FR et al. 1995). After that, many other plant 
defensins have been identified as purified proteins or deduced from cDNA, about 371 plant 
defensins have been so far characterized and reported in the literature (Carvalho AO and 
Gomes VM, 2009), considering these molecules ubiquitous among plant kingdom. 
Plant defensins have been originally described as small multigene family as 
demonstrated by the identification of 15 genes encoding plant defensins in Arabidospis 
thaliana genome. Further studies revealed that the defensin family was fairly larger, about 
300 DEFensin-Like (DEFL) genes have been identified in A. thaliana (Silverstein KA et 
al. 2005) 
Defensin gene structure is characterized by two exons interrupted by one intron of 
variable size. The first exon almost entirely encodes for the signal peptide and the second 
one encodes for the typical cysteine-rich domain. The signal peptide at the N-terminus is a 
typical hallmark for plant defensins and is considered necessary for their extracellular 
localization. However, recently, the plant defensin AhPDF1.1 from A. thaliana has been 
identified into the intracellular compartment, indicating possible different targeting 
functions for this peptide (Oomen RJFJ et al. 2011).  
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Several studies indicated that the expression of DEFL genes is highly variable. In 
normal physiologically conditions defensins have been found to be specifically expressed 
in plant tissue or developmentally regulated. DEFL transcripts are commonly abundant in 
reproductive tissues, such as flower, fruit and seed and, for different species, they can be 
found also in leaf, root and bark tissues (Terras FRG et al. 1995, Wisniewski ME et al. 
2003, Fossdal CG et al. 2003). The constitutive expression of plant DEFL is consistent 
with a role in first-line defense of vulnerable tissues. Furthermore, the expression of 
several plant DEFLs is reported to be induced upon biotic and abiotic stress such as toxic 
level of salt (An SH et al. 2008) and zinc (Mirouze M et al. 2006), or fungal infection and 
wounding (Meyer B et al. 1996, Penninckx IAMA et al. 1996). For examples Terras and 
co-workers showed the gene expression of two defensins (RS-AFP3 and Rs-AFP4) in 
leaves of R. sativus upon Alternaria brassicola infection (Terras et al. 2005). A systemic 
transcript accumulation of PDF1.2, a defensin from A. thaliana, has been reported in 
arabidopsis plants infected by A. brassicola, involving ethylene and jasmonate pathways 
(Manners JM et al. 1998). It is commonly accepted that plant hormones as ethylene, 
salicylic acid, jasmonate acid and its analogue methyl jasmonate are variously implicated 
in signal transduction pathways that lead to the production of antimicrobial proteins.  
Despite the low percentage of similarity in the primary sequence, plant DEFLs share 
conserved cysteine residues engaged in disulphide bridges stabilizing their tertiary 
structure. Plant DEFLs form a characteristic motif known as cysteine stabilized αβ motif 
(CS αβ) (Cornet B et al. 1995) and recognizable in the primary structure as 
C…CXXXC…C…CXC.. 
Another motif conserved among disulphide-containing antimicrobial peptides and in 
plant DEFL structure is GXC(X3-9)C (Yount NY et al. 2004). This one, named γ-core 
motif, is structured in two antiparallel β strands with an interposed loop. 
 Three dimensional structure of some plant defensins has been resolved by NMR 
spectroscopy and the global fold, as typified by Rs-AFP1 (Fant F et al. 1998) (Figure 1.4), 
is an α-elix and a triple stranded antiparallel β-sheet stabilized by three intra-molecular 
disulphide bridges.  
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Figure 1.4 Three-dimensional structure of the plant defensin Rs-AFP1 (Fant F et al. 1998). In the figure 
the Cys side chains are represented in ball and sticks.  
A wide range of biological activities has been associated to plant defensins, among 
these the ability to inhibit digestive enzymes such as α-amilases and serine proteinases. 
This function is related to plant protection role against insects. Other defensins are capable 
to inhibit protein translation and act as ion channel blockers. However, the most 
investigated activity of plant defensins is the growth inhibition of microorganisms. Plant 
defensins are mainly active against fungi and only few defensin peptides are known for 
their antibacterial function. For example VaD1, a defensin from Azuki bean, is able to 
inhibit Xanthomonas campestris and Staphylococcus epidermidis with IC50 of 40.8 and 
36.6 μg/ml respectively (Chen CH et al. 2005). Interestingly, the majority of animal 
defensins are mainly known for their antibacterial activity.  
Low concentrations of plant defensins show growth inhibition of a large spectrum of 
fungal species including Aspargillus niger, Neurospora crassa, A. brassicola, A. solani, 
Botrytis cinerea, Fusarium oxysporum, Peniciullium expansum and Fusarium solani. 
Furthermore, microscopical analyses revealed that some defensins are able to cause hyphae 
hyperbranching and swelling, classifying them as morphogenic defensins. HcAFP1, 2, 3 
and 4, the four defensins recently identified from African Brassicacea species, show 
different level of hyper-branching morphology in F. solani (Figure 1.5) (de Beer A and 
Vivier MA, 2011). 
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Figure 1.5 Effect of morphogenic defensin on fungal growth. Light microscope pictures of F.solani 
hyphae treated with the peptide Hc-AFP1 (on the left) and untreated (on the right). (de Beer A and Vivier 
MA, 2011) 
An important feature shared by plant defensins (and in general by cationic 
antimicrobial peptides) is the electrostatic interaction between positive charges of the 
protein and the negative residues typically present in the outer layer of the microbial 
membrane. This is supported by the reduced antimicrobial activity of several plant 
defensins when the ionic strength of the fungal growth assay medium is increased. For 
examples MsDef1 (a defensin from Medicago truncatula), that strongly inhibits the growth 
of Fusarium graminearum in vitro, shows a reduced antifungal action in presence of Ca
2+ 
(Spelbrink RG et al. 2004). With increasing peptide concentration, the peptide molecules 
insert into the bilayer and lead to the distruption of membrane barrier function by different 
mechanisms: (i) the “barrel-stave model”, which involves the formation of a permanent 
pore by the oligomerization of amphipathic peptide, in order to form a hydrophilic channel, 
(ii) the “toroidal pores model”, in which the pore includes lipid head groups to stabilize the 
high positive charge of the peptides and (iii) the “carpet model”, where layering of 
positively charged proteins on the plasma membranes causes destabilization in a detergent-
like manner (Brogden KA et al. 2005). 
The ability of plant defensins to induce membrane permeabilization has been widely 
shown by in vitro test against different fungi treated with SYTOX green, a fluorescent dye 
able to enter into the cells only in presence of compromised plasma membranes. 
Research on the antifungal mode of action of plant defensins pointed already more 
than a decade ago to their interaction with specific binding sites in fungal membranes. 
Using the radiolabeled plant defensins DmAMP1 and HsAFP1, isolated from Dahlia 
merckii and Heuchera sanguinea, respectively, specific binding of these defensins on 
fungal cells and on microsomal membranes was demonstrated (Thevissen K et al. 1997; 
Thevissen K et al. 2000). Later, the identity of the DmAMP1 receptor on yeast membranes 
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was uncovered as specific inositolphosphoryl-containing sphingolipids. Also the receptor 
for RsAFP2, a plant defensin from radish, was identified on fungal and yeast membranes 
as another class of sphingolipids, namely glucosylceramide (Thevissen K et al. 2003). 
Apart from being an important structural component of eukaryotic membranes, 
sphingolipids are also recognized as secondary messenger molecules regulating the 
equilibrium between cell death and cell growth processes (Thevissen K et al. 2006). The 
structural differences between fungal/yeast and human sphingolipids could be responsible 
for the preferential interaction of plant defensins with fungal/yeast membranes compared 
to  plant or human ones, explaining their low toxicity (Thevissen K et al. 2006). 
Recently, new data have shown that membrane damage is only one among several 
mechanisms involved in the antibiotic action of defensins (Aerts et al., 2008). After the 
initial interaction between plant defensins and fungal membranes, several processes have 
been reported: RsAFP2 shows antimicrobial activity against the human pathogen Candida 
albicans through the induction of endogenous reactive oxygen species (ROS) (Aerts AM et 
al. 2007) whereas MsDef1 induces L-type Ca
2+
 channel blocking in mammalian cells 
(Spelbrink RG et al. 2004), suggesting that this mechanism can possibly regulate MsDef1 
antimicrobial action also against fungal pathogens. Psd1, a defensin from pea, inhibits 
Neurospora crassa fungal growth by affecting the normal progression of the cell cycle 
after cell internalization and interaction with fungal cyclin F (Lobo DS et al. 2007).  
Site-specific mutagenesis studies investigated on the importance of the amino acid 
composition and the charge distribution of solvent-exposed loops for the antimicrobial 
activity of plant defensins. In vitro antifungal studies of mutated forms of MsDef 1 and 
MsDef 4 (another defensin from M. truncatula), using F. graminearum as fungal target, 
show that there is a positive correlation between the positive charges content of defensins 
and their antifungal activity. However, also hydrophobicity is crucial for defensin action, 
since its increase could compensate net positive charge decrease (Sagaram US et al. 2011). 
To gain a better molecular insight in the interaction between plant defensins and their 
sphingolipids receptors, the backbone dynamics of Psd1 and Sd5, a defensin from 
sugarcane, were probed and their interaction with membrane vescicles added with GlcCer 
was investigated (de Medeiros LN et al. 2010; de Paula VS et al. 2011). Both these studies 
showed that specific regions of the plant defensins are responsible for their ability to 
interact with GlcCer, ensuring anchorage to fungal membranes. Interestengly, the dynamic 
properties of Sd5 are completely different from those of Psd1, demonstrating that although 
defensins share similar threedimensional structures, their dynamic can be extremely 
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diverse.  
The antimicrobial activity of defensin peptides has been widely studied in vitro. The 
recombinant overexpression of some defensins in planta showed that these peptides play 
also an important defense function in planta. For example, constitutive expression of 
NmDef02 (a defensin from Nicotiana megalosiphon, that displays a strong antimicrobial 
activity in vitro against important plant pathogens) in tobacco and potato plants enhanced 
their resistance against Phytophthora parasitica (Portieles et al. 2010) (Figure 1.6). 
Furthermore, overexpression of wasabi (Japanese horseradish) defensin (WT1) in rice and 
potato resulted in increased resistance against Magnaporthe grisea, Erwinia carotovora 
and B. cinerea (Kanzaki et al. 2002).  
 
Figure 1.6 Effect of overexpression of plant defensin in planta. Phenotype of tobacco plants transformed 
with NmDef02 (a and d) and empty vector (b and c), after Phytophthora parasitica inoculation (Portieles et 
al. 2010).  
In vitro and in planta antimicrobial activities of plant defensins make these peptides 
attractive for biotechnological applications: they represent good candidates (1) for 
developing transgenic plants with increased resistance to pathogens and (2) for productin 
of natural antimicrobial peptides:  
(1) Transgenic plants have the potential to provide broad resistance against different 
pathogens and reduce dependence on chemical pesticides. As reported above, several plant 
defensins have been successfully transformed into tobacco, potato and other plant species. 
However, at the moment, especially in European countries, the introduction of transgenic 
plants into agriculture has been vigorously opposed, mainly for the risk to mix transgenic 
and non transgenic crops and for the possibility of endangering native or non target 
species.  
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(2) The study of natural antimicrobial peptides as alternative to chemical pesticides 
or in general as drugs is currently under investigation. The increased use in the last decades 
of antibiotics in biomedical and agriculture fields has led to the emergency of more 
resistant and virulent strains of pathogens and the urgent need for highly effective 
antimicrobials. The use of antimicrobial peptides (AMPs) is a promising approach for 
several interesting characteristics: they feature (a) broad-spectrum antimicrobial activity 
against fungi, bacteria and virus, (b) small dimension (c) high protein stability (d) low 
IC50 values, (e) synergism with other AMPs, (f) low toxicity against mammal cells and (g) 
as part of the non-host resistance, pathogens will not develop resistance. The reduced 
toxicity towards animals could be explained by the dependence of membrane interaction 
caused by AMPs to lipid composition of the target membrane; it’s known that there are 
differences between plant, animal and yeast/fungal membrane composition (Wilmes et al. 
2011). 
Plant defensins have all positive characteristics here reported, however, production 
of recombinant defensins is difficult and expensive. Until now, the cost associated with 
defensin production has represented the major obstacle for the widespread use of these 
peptides as antimicrobial agents. The recombinant expression of plant defensins in 
Escherichia coli or Pichia pastoris is commonly performed for in vitro antimicrobial 
activity test, but with these systems the final protein yield is generally low, representing a 
obvious problem for the mass production. 
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2 PROJECT AIM 
Before this study, only one defensin in peach, PpDFN1 (Wisniewski ME et al. 2003), 
and one in grapevine, VvAMP1 (de Beer A and Vivier MA 2008), were known. Moreover, 
there were no data available regarding the antifungal activity of PpDFN1. The main 
objective of this work was the characterization of the antimicrobial activity and the mode 
of action of PpDFN1 and identify and study novel DEFL (DEFensin Like) peptides from 
grapevine.  
A prerequisite for these objectives was the development of a suitable protocol for 
their production and for this reason a consistent part of this PhD work was invested in 
developing protocols suitable for the recombinant expression and purification of peach and 
grapevine DEFLs. Several studies reported the difficulties to produce reasonable yields of 
these small peptides in heterologous expression systems. Production of DEFLs with a 
quick, easy and cheap protocol is considered a preliminary step in order to study antifungal 
properties and for a possible future exploitation as antimicrobial peptides in different 
fields.  
The antimicrobial activity of peach and grapevine DEFLs was investigated using 
different techniques, such as fluorescence microscopy, monolayer technique and 
mutagenesis studies. Understanding mechanism of action involved in the susceptibility of 
fungi to DEFLs may provide new insight into the inhibitory activity of these antimicrobial 
peptides and lead the development of new antifungal compounds in agriculture.  
 
The biological role of PpDFN1 in peach has been analyzed by studing the Ppdfn1 
gene expression in flower, fruit and leaf and its induction in fruits upon Monilia laxa (the 
main fungal pathogen infecting Prunus spp.) infection. 
In order to characterize the PpDFN1 activity, the peptide was overexpressed in 
Escherichia coli as recombinant protein and purified to homogeneity through 
chromatographic techniques. The purified recombinant PpDFN1 was tested against fungal 
and bacterial pathogens and its mechanism of action was investigated using different 
strategies. The PpDFN1 ability to permeabilize the membranes of sensitive fungi was 
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analyzed by fluorescence microscopy and its interaction with lipids investigated using 
monolayer techniques. The affinity of PpDFN1 for different lipids was studied using 
monolayers composed of lipids of different origin.  
 
In the laboratory of Dr. Moser at FEM-IASMA (Trento, Italy), 79 sequences 
encoding for DEFL peptides were identified in grapevine (Giacomelli L et al. paper 
submitted), by scanning the V. vinifera sequenced genome (Velasco R et al. 2007). The 
identified sequences were included in four groups depending on their cysteine pattern, and 
candidates from each group, displaying a different gene expression pattern, were selected 
for the recombinant expression in E. coli. The purified recombinant peptides (DEFL 13, 22 
(VvAMP1), 31 and 59) were tested in vitro for their antimicrobial activity against Botrytis 
cinerea; DEFL 13, showing the strongest antifungal potency, was selected for investigation 
on the mechanism of action, using different techniques. Among these, a B. cinerea mutant 
library, depleted in genes encoding for signal transduction proteins, was screened in order 
to identify possible pathways involved in DEFL 13 antifungal action. In addition, site-
direct mutagenesis of DEFL 13 was performed to identify key residues important for 
protein activity. 
 
During the PhD, I have had the possibility to work for six months in the laboratory of 
Dr. Mark Banfield (Biochemestry Laboratory. John Innes Centre, Norwich. UK). During 
this experience I optimized the cloning, the expression and the protein purification of 
grapevine DEFLs, which allows me to familiarize with  the protein chromatography 
AKTA system (GE Healthcare). I also worked for two months in the laboratory of Prof. 
Paul Tudzynsky (Biology and Biotechnology of fungi. University of Muenster, Germany), 
where I had the possibility to screen the DEFL 13 action against a collection of B. cinerea 
signaling mutants. Both these experiences represented fundamental steps of my PhD, 
considering the results obtained further to my personal and professional formation.  
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3 MATHERIALS AND METHODS 
3.1 Gene expression, antimicrobial activity and membrane 
interaction of the peach (Prunus persica) defensin PpDFN1 
3.1.1 BLAST search of peach DEFLs 
To identify DEFL encoding genes, the peach (Prunus persica) genome predicted 
peptide V 1.0 (http://www.rosaceae.org) database was scored by BLAST search using 
PpDFN1 as query. Retrieved peptide sequences were aligned using CLUSTAL X software 
(Larkin MA et al. 2007) and the percentages of identity and similarity were calculated 
using EMBOSS software (Rice P et al. 2000). 
3.1.2 RT-qPCR analysis of Ppdfn1 gene expression 
Leaves, flowers and fruits (at different ripening stages: S1- enlargement of pericarp; 
S2- pit hardening; S3- enlargement of the mesocarp; S4- climacteric phase) of the peach 
(Prunus persica) cv K2 were harvested from a local fungicide-free orchard (Bologna-
Italy). The whole leaves and flowers and the peel of the fruits were immediately frozen in 
liquid nitrogen. S3-stage fruits were inoculated with a conidial suspension of Monilia laxa 
at a concentration of about 10
6
 conidia/ml. Three replicates of 15 fruits each were dipped 
for 1 min in the fungal conidia suspension or in water for the control. The peach fruits were 
then conserved at 20°C for 24 and 48 h and the peel samples were immediately frozen in 
liquid nitrogen. Total RNA was isolated from each tissues (leaf-flower-S1,S2,S3,S4-fruits 
and S3 M. Laxa and mock inoculated fruits), following the protocol published by Bonghi et 
al. (Bonghi C et al. 1992) with some modifications. Briefly, 0.2 g of frozen tissues were 
ground to a fine powder in liquid nitrogen with mortar and pestle and the ground tissue was 
suspended in 800 μl of 65°C preheated extraction buffer and leaved at 65°C for 10 min. 
One volume of 65°C preheated phenol was added to the mixture and samples were 
centrifuged at 14000 g for 6 min. The upper phase was extracted with en equal volume of 
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phenol:chloroform:isoamylalchol (25:24:1), re-centrifuged and re-extracted with one 
volume of chloroform:isoamylalchol (24:1). After centrifugation at 14000 g for 6 min, the 
RNA was precipitated in one volume of isopropyl-alcohol and 0.3 M sodium acetate (pH 
4.8), washed with 70% ethanol and resuspended in TBE (Tris/Borate/EDTA). RNA was 
then precipitated in 3M LiCl overnight at 4°C, centrifuged at 30000 g for 30 min and 
washed with 70% ethanol. The pellet was resuspended in 30 μl of DEPC 
(DiethylenePyrocarbonate)-treated water. DNA was removed from the samples by Turbo 
DNase treatment (Ambion) following the manufacturer’s instructions. RNA purity was 
analyzed by measuring the A260:A230 and A260:A280 ratios and the quantity was 
calculated from the adsorbance at 260 nm. In order to analyse the integrity of the samples 
0.5 μg of RNA was run on agarose gel (Figure 2.1). 
 
Figure 3.1. Agarose gel of total RNA samples. The integrity of RNA was indicated by the presence of the 
two ribosomal RNA bands. In the last lane the 1kb Gene Ruler (Fermentas) was loaded. 
The first strand cDNA was synthesized from 500 ng of total RNA using the ImProm-
II Reverse TranscriptaseTM kit (Promega), following the manufacturer’s instructions. 
Suitable primers for Real Time PCR were designed to specifically amplify Ppdfn1 and 
actin (as normalizer) genes using the software Primer3 (http://frodo.wi.mit.edu/primer3/-
primer3code.html). Primer sequences were as following 
Ppdfn1: Forward primer 5’CGCTCCATGCGTTTATTTTC 
              Reverse primer 5’TCACAGGTCCTAGCCTCAGC 
Actin: Forward primer 5’ATCATGTTTGAGACCTTCAATG 
           Reverse primer 5’AGAGTCCAGCACAATACCAGTT 
The primers were synthesized by PRIMM srl. 
Real Time PCR was performed on MX3000 machine (Stratagene) using the Brillant 
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SYBR Green qPCR Master mix (Stratagene). Three biological replicates for each sample 
and two technical replicates of each reaction were always run in the same experiment. All 
thermal cycles started with an initial denaturation step at 95°C for 10 min, followed by 40 
cycles consisting of a denaturation step at 95°C for 30 sec, an annealing step at a specific 
temperature (60°C for the Ppdfn1 and 58°C for actin) and an extension step at 72°C for 1 
min. Quantification was carried out using the standard curve generated by serial dilutions 
of a cDNA first strand randomly chosen. Data were analyzed using MXPro QPCR 
Software, Version 3.0 (Stratagene).  
3.1.3 Cloning, expression and purification of PpDFN1 
The cDNA encoding for PpDFN1 mature peptide was amplified from total cDNA 
generated from fruit at the S2 ripening stage. Specific oligonucleotides were designed and 
the restriction enzyme recognition sites (BspHI in the forward and HindIII in the reverse 
primer) were introduced to insert the gene in the multi-cloning site of pHAT (Peranen J et 
al. 1996) and pET32 (Novagen). Both the vectors are selected for the ability to produce a 
N-terminal His-tagged protein; pET 32 is designed for also adding a thioredoxin (TRX) as 
N-terminal fusion protein.  
Forward primer 5’ TATATCATGAGGACCTGTGAGTCTCAGAGTAAT 
Reverse primer 5’ TATAAAGCTTTTAACAATGTTTAGTGCAAAAGC  
The restrictions sites introduced are underlined. The primers were synthesized by 
PRIMM srl. 
The PCR was performed with 25 pmol of each primer, 2 mM dNTP mix, 1.5 mM 
MgCl2, 1x buffer and 1 U of GoTaq polymerase (Promega). PCR started with an initial 
denaturation step at 95°C for 5 min, followed by 35 cycles (95°C for 1 min, 60°C for 45 
sec and 72°C for 45 sec) and a final extension at 72°C for 5 min. PCR amplification was 
analyzed on agarose gel and purified with Nucleospin Extract II kit (Macherey-Nagel) 
following the manufacturer's instructions. The total amount of purified PCR product was 
digested with 25 U of each restriction enzyme (Fermentas) at 37°C for 3 h. The digested 
PCR product was gel-purified (Nucleospin Extract II kit Macherey-Nagel), eluted in sterile 
water and quantified on agarose gel. 60 ng of purified PCR product was ligated with 18 ng 
of digested (with the NcoI and HindIII digestion enzymes) pHAT or pET32 vectors by 2 U 
of T4 ligase (NEB) and incubated at 16°C overnight. The recombinant plasmids were 
introduced in E. coli DH5α strain by electroporation and transformed cells were grown 
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overnight at 37°C in Luria-Bertani solid media. For plasmid selection, ampicillin (100 
μg/ml) was added to all media. Liquid cultures were prepared from a single colony and the 
cells were grown in LB media with agitation. Plasmids were purified using the Nucleospin 
Plasmid kit (Macherey-Nagel). 
DNA fragments cloned into the plasmids were sequenced by BMR-genomics 
(www.bmr-genomics.it) using the universal T7 forward primer 
(5’TAATACGACTCACTATAGGG-3’). The chromatograms were analyzed with 
Chromas software available on the BMR-genomics website. 
The recombinant vectors were introduced in E. coli BL21(DE3) Origami cells 
(Novagen) by electroporation. Origami host strain has a mutations in both the thioredoxin 
reductase (trxB) and glutathione reductase (gor) genes, which enanche disulphide bond 
formation in the cytoplasm. Bacterial cultures were grown in LB medium supplemented 
with ampicillin (100 μg/ml) at 37°C by shaking up to an absorbance value of about 0.5 at 
600 nm. The protein expression was induced for 3 h at 37°C or overnight at 20°C by 
adding 0.4 mM isopropyl 1-thio-b-D-galactopyranoside (IPTG). A small scale expression 
test was performed and the production of recombinant protein was checked in SDS-PAGE 
gel, in order to select the vector and to chose the optimal expression conditions. 
The pellet obtained from E. coli BL21 Origami transformed with recombinant pET32 
and induced overnight at 20°C was resuspended in 50 mM phosphate buffer, 300 mM 
NaCl, 20 mM imidazole, 10% glycerol, pH 8 and lysed by French press (SLM AMINCO I) 
at 1200 psi. The lysate was centrifuged and the filtered (0.45 µm) supernatant applied to 
pre-equilibrated 5 mL Ni
2+
-NTA (nickel-nitrilotriacetic agarose) columns (GE Healthcare). 
After a wash with a washing buffer containing 20 mM of imidazole, the protein was eluted 
with 200 mM imidazole. Fractions containing fusion protein (as identified by SDS-PAGE 
gel) were pooled, concentrated and dialyzed against digestion buffer (20 mM Tris-HCl, 50 
mM NaCl, 2 mM CaCl2, pH 8). TRX-6xHis tag was removed by enterokinase (Novagen) 
digestion (0.0001% w/w) overnight at 20°C. PpDFN1 was further purified by cationic 
exchange chromatography (MonoS, GE Healthcare); a NaCl gradient was performed to 
separate the proteins with different calculated pI. 
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Protein Molecular weight pI Coefficient  of extinction 
TRX-6xHIS-PpDFN1 22409.3 6.40  
PpDFN1 5437,2 9,17 500 
TRX-6xHIS 16990.1 5.33  
Enterokinase 26306.8 5.35  
Table 3.1 Biochemical features reported for TRX-6xHis-PpDFN1, PpDFN1, TRX-6xHis and 
enterokinase. The parameters reported in the table are calculated using the free program Protparam 
(http://web.expasy.org/protparam). 
Fractions containing PpDFN1 were pooled, concentrated and dialyzed in phosphate 
buffer, 150 mM NaCl, pH 8. PpDFN1 was spectrophotometrically quantified 
(Spectrophotometer ND-1000, Nanodrop) based on absorbance at 280 nm reported in the 
table 3.1 and checked for purity in SDS–PAGE gel.  
3.1.4 Antimicrobial activity of recombinant PpDFN1 
For in vitro antifungal activity test, fungi (Botrytis cinerea, Penicillium expansum 
and Monilia laxa) were grown on potato dextrose agar (PDA, Difco). The PpDFN1 
antifungal activity was assayed by evaluating inhibition of conidia germination of M. laxa, 
B. cinerea and P. expansum. Percentage of inhibition was measured by spectrophometer in 
a 96-wells micro-titer plate; each well contained 100 μl of water and 1% glucose, 2000 
spores and 40-0 µg/ml of purified PpDFN1. Control reactions contained protein buffer 
without peptide. Plates were incubated at 20°C and the spetrophotometric readings were 
taken every 24, 48 and 72 h at 620 nm. All readings were corrected by subtracting the time 
zero readings. Each assay was independently repeated three times with three technical 
replicates per measurement. Percentage of growth inhibition was calculated as follow:  % 
of growth inhibition = 100 x (Acontrol – Asample) / Acontrol , where A is the corrected 
absorbance at 620 nm of the control or the sample.  
The IC50 values of PpDFN1 were calculated after 72 h of incubation. 
Antibacterial activity of PpDFN1 was similarly assessed in a 96 wells micro titer 
plate. Wells contained 100 µl of minimum media (M9 Minimal salt, Sigma-aldrich), 
bacterial culture at OD600 of 0.1 and 100 µg/ml of PpDFN1. The control reactions 
contained protein buffer without peptide. Plates were incubated by shaking for 48 h at 
37°C and the bacterial growth was monitored by measuring the absorbance at 600 nm 
every 24 h. The assay was used to test antimicrobial activity against Xanthomonas 
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campestris, Psedumonas auroginosa and Agrobacterium tumecians and against Listeria 
monocitogenes and Salmonella enteritidis. The same assay was performed also for the 
yeast Saccharomyces cerevisae.  
3.1.5 Fluorescence microscopy analysis 
SYTOX green (Invitrogen) assay was performed as previously reported by Thevissen 
and co-workers with some modifications (Thevissen K et al. 1999). Briefly, water and 1% 
glucose containing M. laxa, B. cinerea or P. expansum (2.5 x 10
4
 conidia/ml) were 
incubated for 18 h at 20°C. PpDFN1 at concentration of 40 µg/ml and SYTOX green (1 
µM) were added and after 6 h of incubation (at the dark) the germinated conidia were 
analyzed using a Dialux 20EB, Leitz microscope. Samples were excited at 504 nm and the 
SYTOX green fluorescence was monitored at 523 nm. Images were captured and 
processed using Nikon Eclipse TE2000-E program.  
3.1.6 Monolayer measurements 
The monolayer experiments were performed with a commercial apparatus (μTrough 
S; Kibron) enclosed in a plexiglass cabinet and connected to a computer. The surface 
pressure π of the lipid monolayer is defined as the decrease in surface tension γ, i.e., π=( 
γo- γm), where γm and γo represent the surface tension of the water/air interface in the 
presence or absence of the lipid monolayer. It was measured by the Wilhelmy method, 
using a 2 mm diameter platinum wire, which ensures a zero contact angle. Before each 
experiment, the trough and the wire were thoroughly cleaned with hot water and organic 
solvents, followed by a final wash in MilliQ water. Solutions were stirred with a thin 
teflon-covered magnetic bar. All measurements were made at 23°C. To minimize the 
amount of defensins required, the experiments were performed in a small, home-made, 
circular teflon trough (total surface 2.54 cm
2, total volume 800 μL). Defensin was injected 
directly into the subphase through a hole drilled in the trough wall. Before the protein was 
applied, a lipid monolayer was prepared adding lipids in small drops on the top of the 
buffer surface until the desired initial surface pressure was reached. To attain a steady 
state, the monolayer was allowed to stand for at least 30 min before the defensin was 
injected. The experiments were performed preparing the monolayer with different lipids, 
reported in the table 2.2.  
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Abbreviation Type of lipids Comments 
P Total lipids of P. Expansum Folch extraction* 
M Total lipids of M. Laxa Folch extraction* 
B Total lipids of B. Cinerea Folch extraction* 
ePC:cer egg L-α-phosphatidylcholine bovine and brain ceramide β-D-galactoside 2% Commercial lipids (Sigma-Aldrich) 
ePC egg L-α-phosphatidylcholine Commercial lipids (Sigma-Aldrich) 
RBC Total lipid of human erythrocyte Folch extraction* 
Table 3.2 Different lipids assayed in monolayer experiments. In the table, the abbreviation, the ype of the 
lipids and the comments about the origin of the lipids are reported. Before use the commercial lipids were 
dissolved in chloroform/methanol solution (2:1 v/v) up to lipid concentration of 25 μg/ml. Red blood cells 
were centrifuged from freshly collected blood (from healthy volunteers) and washed three times with vesicles 
buffer (10 mM Hepes, 140 mM KCl and 0,1 mM EDTA pH 7.4) before the Folch extraction. 
* Folch extraction (Folch J et al. 1957). Briefly 20 mg cells and 3 ml solution (10 mM Tris, 250 mM sucrose 
pH 7) were homogenized on ice using homogenizer Ultra Turrax T8 (IKA Labortechnik) and 20 mg glass 
beads (212-300 μm, Sigma-Aldrich) followed by centrifugation (5000 g, 20 min, 4°C). The supernatant was 
extracted with chloroform/methanol (2:1 v/v) and separated from the sediment by centrifugation (5000 g, 30 
min, 25°C). The sediment was re-extracted with chloroform/methanol (1:2 v/v) and supernatants were 
combined, dried by rotary evaporation and dissolved in chloroform/methanol/distilled water (54:31:15v/v) 
mixture. The solution was shaken vigorously and the two phases were separated by centrifugation (600 g, 20 
min, 25°C). The lower phases was re-extracted sequentially with chloroform/methanol/distilled water 
(37:34:29 v/v) mixture. Finally the lower phase was dried by rotary evaporation and kept at -20°C under gas 
nitrogen. Before using they were dissolved in chloroform/methanol solution (2:1 v/v) at 25 μg/ml. 
3.2 Identification and characterization of the defensin-like 
gene family in grape (Vitis vinifera) 
3.2.1 Genome identification of DEFL sequences and analysis of their 
primary structure 
The identified grapevine DEFLs (Giacomelli L et al. paper submitted) were aligned 
using CLUSTAL X software (Larkin MA et al. 2007) and the groups were formed 
considering the cysteine residues pattern.  
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3.2.2 Selection of grapevine DEFLs, recombinant expression, 
purification and antimicrobial activity 
Primers containing specific extensions (table 3.3) were used to amplify the mature form of 
DEFL 1, 13, 22, 31 and 59 from cDNAs.  
DEFL Forward primer (5’-3’) Reverse primer (5’-3’) 
1 AAGTTCTGTTTCAGGGCCCGCAAGATCCAGGGAGTGATTG ATGGTCTAGAAAGCTTTAAGCAATAATACAACAACAAC 
13 AAGTTCTGTTTCAGGGCCCGCAACAAGATGGAAGGTGTTGCAA ATGGTCTAGAAAGCTTTAACAATAACAATGACAAACATGACGA 
22 TATATCATGAGGACCTGAGAGTCAGAGCCAC TATAAAGCTTTTAACAATGCTTAGTGCAGAAGC 
31 AAGTTCTGTTTCAGGGCCCGGCGGATCCACAAAAAAGTTGC ATGGTCTAGAAAGCTTTAACAAGGGTACATGTACAC 
59 AAGTTCTGTTTCAGGGCCCG AAGGAGGTTAAGGCAGCGAGG ATGGTCTAGAAAGCTTTAACAGTTGTAATAGCAAATACATTC 
Table 3.3 Forward and reverse primers used for the cloning in expression vectors. For the DEFL 22 the 
restriction sites (BsphI in the forward and HindIII in the reverse primer) and the “tata” sequences are 
underlined. For the other DEFLs, appropriate In-FusionTM extensions are underlined. The primers were 
synthesized by PRIMM srl. 
(a) DEFL 22 (VvAMP1) 
The amplification product of DEFL 22 was cloned into pHAT (Peranen J et al. 1996) 
and pET32 (Novagen) vectors for the recombinant expression. The cloning strategy, the 
protein expression and the purification protocols were the same used for PpDFN1. 
(b) DEFLs 1, 13, 31 and 59 
A versatile ligation-independent cloning method was pursued for DEFL 1, 13, 31 and 
59 (Berrow et al. 2007). Appropriate primer extensions were used to enable In-Fusion
TM
 
cloning into the digested pOPIN F and M vectors to obtained the desired 6xHis-tagged 
proteins. PCRs were performed in 50 μl reaction mixes using TAQ polymerase 
(Invitrogen), with 30 pmol of each forward and reverse primers and either 0.5 ng of the 
cDNA (from inflorescence for DEFL 13 and 59, from seed for DEFL 31 and from fruit for 
DEFL 22) as template per reaction. The resulting PCR products were separated by 
electrophoresis on a 1% w/v agarose TBE gel and purified from the gel using the 
QIAquick
TM
 kit modified for gel extraction (Qiagen). Purified PCR products were eluted 
from the QIAquick
TM
 columns in 50 μl of pure water. About 100 ng of purified PCR 
products and 100 ng of the linearized pOPIN F or M vector were mixed in the wells of an 
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In-Fusion
TM
 Dry-Down (Takara-Clontech) and incubated at 42°C for 30 min. All reactions 
were diluted 1:5 with TE Buffer (10mM Tris, 1mM EDTA pH 8.0) and 15 μl were used to 
transform chemical competent E. coli DH5α cells by heat shock method. The 
transformants were selected by plating on LB Agar plates supplemented with the 
carbecillin (100 μg/ml), 0.02% w/v X-Gal and 1mM IPTG and incubating overnight at 
37°C. The positive white colonies were inoculated in LB supplemented with carbecillin. 
The cultures were used for plasmid preparation using the kit Wizard plus Miniprep 
(Promega), following the manufacturer’s instructions. Plasmids were screened using the 
PCR protocol described above for DEFL amplifications except the forward primer which 
was replaced with the standard T7 forward primer. The PCR products were analyzed by 
electrophoresis on a 1 % w/v Agarose TBE gel and DNA fragments were sequenced by 
BMR-genomics. The chromatograms were analyzed with Chromas software available on 
the BMR-genomics website and positive recombinant vectors were transformed into 
chemical competent E. coli Origami strain (Novagen) by heat shock. The plates were 
incubated for 18 h at 37°C before individual colonies were used for small scale expression 
test. Bacterial cultures were grown in LB medium supplemented with carbecillin (100 
μg/ml) at 37°C by shaking up to adsorbance values of about 0.4-0.5.at 600 nm. The protein 
expression was induced by adding 0.4 mM  IPTG for 3 h at 37°C or overnight at 20°C. The 
recombinant expression was analyzed by SDS-PAGE gel for selecting the construct and 
the optimal expression conditions. 
Pelleted cells from 6 l of bacterial cultures able to express the recombinant soluble 
protein (pOPIN M-DEFL 13, 31 and 59 induced overnight at 20°C) were resuspended in 
lysis buffer (50 mM Tris-HCl, 500 mM NaCl, 20 mM imidazole, 50 mM glycine, 20% 
(v/v) glycerol, pH 8) and lysed by a constant cell disruption systems (CONSTANT 
SYSTEMS LTD). The lysates were centrifuged at 18000 g for 30 min and the filtered 
(0.45 µm) supernatants were applied to pre-equilibrated 5 ml Ni2+-IMAC columns (GE 
Healthcare) and proteins were eluted with 500 mM imidazole. Fractions containing fusion 
proteins (MBP-6xHis-DEFL 13, 31 and 59) were identified by SDS-PAGE gel, pooled and 
concentrated, then injected into a Hi-Load 16/60 Superdex 75 column (GE Healthcare) 
pre-equilibrated with 20 mM HEPES, 150 mM NaCl pH 7.5. The MBP-6xHis tag was 
removed by digestion with C3 protease (12 μg/mg of fusion protein) overnight at 4°C. The 
MBP fusion partner and the 3C protease were removed using MBP and HIS trap columns 
linked in series (5ml, GE Healthcare). The flow through from these columns were 
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concentrated  and injected onto a Hi-Load 16/60 Superdex 75 column (GE Healthcare) pre-
equilibrated with 20 mM HEPES, 150 mM NaCl, pH 7.5. The fractions containing protein 
were pooled, concentrated and their purity was confirmed by SDS-PAGE gel. Proteins 
were quantified by their absorbance at 280 nm (Spectrophotometer ND-1000, Nanodrop ) 
and the concentration was calculated using the corresponding ε (table 3.4).  
DEFLs calculated ε Molecular weight 
13 9105 6417.1 
22 500 5557.3 
31 3480 5554.4 
59 4970 5939.8 
Table 3.4 Extinction factors () and the molecular weights (MW) of mature DEFLs. The parameters 
were calculated by Protparam (http://web.expasy.org/protparam) 
The purified proteins were assayed for quantify the number of free sulfhydryl groups 
in solution using the Ellman’s test Kit (Thermo Scientific) (Ellman GL 1958). 
The in vitro antimicrobial activity against B. cinerea was assayed both by 
microscopical observation of spore germination and by spectrophotometric determination 
of the IC50 values. The in vitro assays were performed in 96-well micro-titer plates 
containing 100 μl half Potato Dextrose Broth (PDB, Difco) with 5 x 104 spores/ml of B. 
cinerea and the purified DEFLs at concentration from 0 to 50 μg/ml. Plates were left at 
20°C for 3 days. After 16 h, conidia germination was checked with an inverted microscope 
to observe some possible morphological changes. Protein buffer and buffer added with the 
reduced and alkylated form of each recombinant DEFL were used as controls. Reduced 
and alkylated forms were obtained by addition of 2 mM Tris[2-carboxyethyl] phosphine 
hydrochloride and incubation for 5 min at 95°C, follwed by addition of 15 mM iodoacetic 
acid to the cooled reaction mixtures and incubated for 30 min in the dark. The samples 
were dialyzed overnight at 4°C against 20 mM HEPES, 150 mM NaCl pH 7.5 and 
quantified.  
Spectrophometric readings were taken after 24, 48 and 60 h at 540 nm and corrected 
for their time zero readings. Grapevine DEFLs activities were scored after 60 h and 
expressed in terms of % of growth inhibition, which is defined as  
100 x (ABS540control - ABS540sample) / ABS540control)  
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where ABS540control and ABS540sample are the corrected absorbance measured at 540 
nm of control (buffer) and sample (DEFLs) respectively. Each activity assay was repeated 
three times with independent B. cinerea cultures. 
3.3 Characterization of the antimicrobial activity of DEFL 13 
from Vitis Vinifera  
3.3.1 Optimization of recombinant DEFL 13 expression and 
purification 
The recombinant expression of DEFL 13 in P. pastoris was tried following the 
instruction reported in “EasySelect Pichia Expression Kit” (Invitrogen). 
Briefly, the cDNA encoding for DEFL 13, depleted of the signal peptide, was 
amplified from total cDNA generated from grapevine inflorescence. Specific 
oligonucleotides were designed for cloning the gene in the pPICZα vector (Invitrogen), 
EcoRI and XbaI restriction enzyme sites were added in the forward and reverse primer 
respectively. In the reverse primers 2 stop codons (TTATCA), 6 codons codifying for 
histidine (GTGATGGTGATGGTGATG) and 3C protease site 
(CGGGCCCTGAAACAGAACTTCCAG) were also introduced.  
Forward primer (5’-3’):  
GTACATgaattccaacaagatggaaggtgttgcaaag 
Reverse primer (5’-3’):  
CATGTAtctagaTTATCAgtgatggtgatggtgatgcgggccctgaaacagaacttccagacaataacaatga
caaacatgacgacc 
The restrictions sites introduced are underlined. The primers were synthesized by 
PRIMM srl. 
DEFL 13 was amplified by PCR (as reported above for grapevine DEFLs cloning) 
and cloned in the vector pPICZα at the corresponding sites. The gene follows the α factor 
signal for secreted expression and AOX1’, the highly methanol-inducible and tightly 
regulated promoter (Figure 2.2). 
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Figure 3.2 Expression vector pPICZα-6xHis-DEFL 13. The recombinant vector was constructed for the 
extracellular expression of DEFL 13 fused to 6xHis-tag and 3C protease recognition site at its C-terminal 
after two stop codons. EcoRI site in the 5’ and XbaI site in the 3’ were also created.   
The recombinant vector was used to transform E. coli DH5α, colony PCR and 
restriction digestion by EcoRI and XbaI were carried out in order to confirm the 
recombinant trasformants. The positive clones obtained were verified by sequencing 
(www.bmr-genomics.it) using 5’AOX universal primer (5’GACTGGTTCCAATTGACAAG) and 
chromatograms were analyzed with Chromas software available on the BMR-genomics 
website. The constructed vector pPICZα-6xHis-DEFL13 was linearized with PmeI, 
purified and transformed in P. pastoris GS115 strain competent cells by electroporation. 
The cells were selected in YPDS plate (yeast extract peptone dextrose) supplemented with 
zeocine (100 µg/ml) and incubated at 30°C for 48 h. Ten colonies of transformed P. 
pastoris were selected for small scale expression test in shake flasks containing 5 ml of 
BMGY (buffered complex glycerol medium) liquid medium until the A600 value reached 
2. The cultures were centrifugated at 3000 g for 5 min and the cell pellets were 
resuspended in 10 ml of BMMY (buffered complex methanol medium) medium (A600 
value of 1). The methanol (5% v/v) was daily added for 5 days and 1 ml of sample was 
collected every day for SDS-PAGE analysis. The extracellular and intracellular proteins 
were checked by SDS-PAGE gel and stained using InVision™ His-tag In-gel Stain 
(Invitrogen), a fluorescent stain specifically formulated for sensitive and specific detection 
of His-tagged fusion proteins. 
The recombinant vector pOPIN M-DEFL 13 was trasformed in E. coli SHuffle strain 
(NEB), a commercial engineered E. coli strain capable of cytoplasmatic expression of 
proteins rich in disulphide bridges.  
Furthermore, in order to decrease the loss of protein during the last purification step 
(size exclusion chromatography), two alternatives were tested: (a) Ni
2+
NTA (GE 
Healthcare) and amylose affinity chromatography (MBPtrap HP GE Healthcare) connected 
in series and (b) cationic exchange chromatography (SP Sepharose High Performance, GE 
Healthcare) both directly performed after the 3C protease cleavage. (a) The sample was 
loaded to pre-equilibrated affinity columns linked in series and the flow through was 
collected. (b) The sample was loaded to pre-equilibrated column and after washing with 
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the buffer A (20 mM HEPES, 150 mM NaCl pH 7.5) a linear gradient up to 100% of 
buffer B (20 mM HEPES, 1 M NaCl pH 7.5) was performed. The fractions corresponding 
to chromatogram peaks were collected and analyzed by SDS PAGE gel. Peaks containing 
the DEFL 13 were pooled, concentrated and their purity was confirmed by SDS PAGE. 
3.3.2 Antimicrobial activity against fungal and bacterial pathogens 
The purified DEFL 13 was assayed in vitro (following the protocol reported above 
for B. cinerea) against several fungal pathogens: Colletotrichum acutatum, Fusarium 
oxysporum, Monilia laxa, Aspargillus niger, Alternaria arboresca, Penicillium expansum 
and Trichoderma spp. Furthermore, the antimicrobial activity of DEFL 13 was tested 
against the plant pathogenic bacteria Agrobacterium tumefaciens and Erwinia amylovora 
in micro plate assay. Wells contained 100 µl of minimum media (M9 Minimal salt, Sigma-
aldrich), bacterial culture at OD600 of 0.1, and 100 µg/ml of DEFL 13 or protein buffer 
without peptide for the negative control reactions. Plates were incubated by shaking for 48 
h at 30°C and the bacterial growth was monitored by measuring the absorbance at 600 nm 
every 24 h. 
3.3.3 Effect of cations on the antifungal activity 
The effect of the DEFL 13 on the B. cinerea conidia germination was tested at 
different concentration of protein (50, 25, 12.5, 6.25 and 3.13 µg/ml) in half PDB medium 
supplemented with 50 mM, 25 mM and 12.5 mM KCl and 5 mM, 2.5 mM and 1.25 mM 
MgCl2. For each medium a negative control consistent in the same volume of protein 
buffer (20 mM HEPES, 150 mM NaCl pH 7.5) was performed. The antimicrobial activity 
of the different concentrations of protein in each medium was analyzed following the 
protocol reported above and the percentage of inhibition was calculated after 24 h of 
peptide incubation. 
3.3.4 Thermal stability of DEFL 13 
The secondary structure of DEFL 13 and thermal treated DEFL 13 was evaluated by 
CD spectroscopy. The protein sample (5 µM) was dissolved in 50 mM phosphate buffer, 
pH 7.5 using a JASCO 810 spectropolarimeter and a cuvette with 0.1 cm path length. Ten 
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spectra were accumulated from 190 to 240 nm at 0.2 nm intervals and averaged to achieve 
an appropriate signal to noise ratio. The spectrum of the buffer was substracted. The same 
experiment was conducted associating protein thermal denaturation (90°C for 10 min). The 
secondary structure composition of the peptide was evaluated using CONTIN tool 
available on the Dichroweb server (Withmore and Wallace, 2004) and the obtained values 
were used to have an estimation of the relative amount of secondary structure elements. 
The thermal treated DEFL 13 was used in order to investigate the thermal stability of 
the peptide, evaluating the percentage of B. cinerea growth inhibition respect to the 
untreated DEFL 13. The antimicrobial activity was analyzed and the percentage of 
inhibition was calculated after 24 h of incubation (as reported above). 
3.3.5 Activity against fungal hyphae and protoplast of B. cinerea 
The ability of DEFL13 to block the fungal growth of B. cinerea was tested against 
the actively growing mycelium. 50 μg/ml of DEFL 13 or the same volume of buffer (for 
the negative control) were added to overnight germinated conidia (5 x 10
4
 conidia/ml of 
half PDB) and the morphological effect of the protein on the fungal hyphae was observed 
by microscope after 2 h of incubation. The spectrophotometric readings were taken at time 
0, 24 and 48 h and the % of growth inhibition was calculated as reported above. 
The antimicrobial activity of the DEFL 13 was assayed against the protoplast of B. 
cinerea, generated following the protocol reported by Schulze Gronover C et al. (Schulze 
Gronover C et al. 2001).   
Briefly, a spore suspension of B. cinerea was inoculated in PDB and incubated for 24 
h in agitation at 20°C. The filtered young mycelium was washed and incubated in agitation 
for 2 h at 28°C with an enzyme solution of 40 mg Novozym 234 (Novo Enzyme products 
Ldt.) for ml of KC solution (600 mM of KCl and 60 mM of CaCl2). The protoplast solution 
was filtered, washed and centrifuged twice at 4000 g for 10 min at 4°C. The pelleted 
protoplast was resuspended in KC buffer. A solution of 5 x 10
4
 protoplasts/ml of half PDB 
and 50 mM glucose were used for the 96 wells plate antimicrobial activity test and the % 
of growth inhibition was calculated after 24 h of DEFL 13 incubation, as reported above. 
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3.3.6 Fluorescence microscopy analysis 
The SYTOX green assay was performed following the instruction reported above for 
PpDFN1, except to the medium that changes from 1% glucose to half PDB and the time of 
protein incubation (from 6 h to 2 h). 
DEFL 13 was labeled with fluorescein isothiocyanate (FITC) via reactive amines, 
through incubation in the dark for 1 h. Unlabeled FITC was removed by filtration in a 
Centricon YM-3 vial (Millipore). The adsorption at 494 nm was determined, and 
subsequently, the degree of labeling was calculated by the following equation:  
dye per protein molecule = (A494 x diluition factor)/ (68000 x protein 
concentration), 
where 68000 is the molar exctintion factor of FITC at 494 nm. The antimicrobial 
activity of FITC-labeled DEFL 13 was tested before fluorescence assays as reported for the 
other antimicrobial assays. A solution of 5 x 10
4
 conidia/ml grown for 18 h in a half PDB 
was treated with FITC-labeled DEFL 13 (50 μg/ml) for 1 h. The fluorescence was 
observed using a Dialux 20EB Leitz microscope. Samples were excited at 488 nm and 
FITC fluorescence was monitored at 509 nm. Images were processed using Nikon Eclipse 
TE2000-E software.  
3.3.7 Screening of DEFL 13 activity on signaling mutants of B. cinerea 
The antifungal activity of DEFL 13 was tested against a collection of knock-out B. cinerea 
mutants depleted to specific genes involved in signaling cascade. This collection (reported 
in Table 3.5) was created by Prof. Paul Tudzynsky and co-workers in the laboratory of 
Biology and Biotechnology of fungi (University of Muenster, DE) and kindly provided for 
this screening.  
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Table 3.5 Knock-out signaling mutants of B. cinerea. In the table the name of the mutant, the replaced 
gene, eventual comment about the signaling pathways and references are reported. 
The mutants were grown on PDA plates for one week before conidia collection. 
DEFL 13 (at concentration of 50 μg/ml) was assayed in vitro in a 96 wells plate against 
each mutant and the percentage of conidia germination inhibition was calculated and 
compared to the wild type B. cinerea (following the protocol reported above). Each assay 
was indipendently repeated three times with three technical replicates for measurements. 
3.3.8 Polyclonal antibody against DEFL 13: production, purification 
and Western Blot analysis 
Polyclonal antibodies against DEFL 13 were produced by Primm srl by immunizing 
two rabbits with synthetic peptide conjugated to ovalbumin (NH2-
DGRCCKDHPKLGHCVP-COOH). Dilution series (1:50, 1:500, 1:5000 and 1:10000) of 
the two serum from rabbit 1 and 2 were tested in Western blot assay against the purified 
DEFL13. The serum from rabbit 1 was selected as the most specific and concentrated and 
was purified by CNBr-sepharose affinity (GE Healthcare), following the protocol 
recommended by Primm srl. Briefly, the serum was loaded on the CNBr-sepharose column 
(GE Healthcare ) previously coupled with the synthetic peptide and eluted with 100 mM 
Glycine, 500 mM NaCl, pH 2.5. The collected fractions were immediately buffered with 
Tris-HCl pH 8 to keep a physiological pH. Finally, each IgG eluted fraction was read at 
280 nm. 
Western blot analysis was conducted on 2.5 µg each of purified DEFL 13 and 
mutants. The peptides were separated on Tricine SDS gel with a low molecular weight 
marker (Novex, Invitrogen). The gel was electroblotted against a PVDF membrane 
(Hybond-P, American Biosciences) which was afterwards blocked for 1 h in blocking 
buffer (50 mM Tris-HCl, 150 mM NaCl, 0.1% (v/v) Tween 20 and 5% (w/v) of skimmed 
milk, pH 7.6) following overnight incubation with the purified primary antibody (diluited 
1:100 in blocking solution). 
Detection of wild type DEFL 13 and mutants was achieved with anti-rabbit IgG-
Alkaline phosphatase secondary antibody (Sigma-Aldrich) and the BCIP/NBT (Sigma-
Aldrich) staining solution (mixture of 5-bromo-4-chloro-3'-indolyphosphate p-toluidine 
salt and nitro-blue tetrazolium chloride), following the manufacturer’s instructions. 
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3.3.9 DEFL 13 mutagenesis 
In vitro site-directed mutagenesis was performed using “Quick change II site directed 
mutagenesis Kit” (Agilent Technologies) and the recombinant pOPIN M-DEFL 13 as 
template. For each mutation, two primers were designed (25-45 bases, Tm>78°C), 
annealing to the same sequence on opposite strand of the plasmid with the desiderate 
mutation in the middle of each primer (Table 3.6).  
Site-direct mutation Primers (5’-3’) 
W30A 
1 CAAATGGTGGAAAATGTGCGACATATTGTATCAC 
2 GTGATACAATATGTCGCACATTTTCCACCATTTG 
L42S 
1 GTTCAAAGGGTGGCTGCTGCAAAAAATTATC 
2 GATAATTTTTTGCAGCAGCCACCCTTTGAAC 
S48F 
1 GGCTTATGCAAAAAATTATCTTTTGGTCGTCATGTTTGTCATTG 
2 CAATGACAAACATGACGACCAAAAGATAATTTTTTGCATAAGCC 
S48K 
1 GGCTTATGCAAAAAATTATCTAAGGGTCGTCATGTTTGTCATTG 
2 CAATGACAAACATGACGACCCTTAGATAATTTTTTGCATAAGCC 
R50Q 
1 CAAAAAATTATCTGGTGGTCAACATGTTTGTCATTG 
2 CAATGACAAACATGTTGACCACCAGATAATTTTTTG 
Table 3.6 Forward and reverse primers used for the site-directed mutagenesis. The primers were 
synthesized HPLC-grade pure by PRIMM srl. 
The PCR reactions were performed following the protocol provided with the kit. 
Briefly, the PCR reaction contained 10 ng of recombinant plasmid (pOPIN M-DEFL 13), 
125 ng of each primer, 1 µl of dNTPs mix and 2.5 U of Pfu Ultra DNA polymerase. The 
PCR program was reported in the table 3.7. 
Segment Cycles Temperature Time 
1 1 95°C 30 sec 
2 16 
95°C 30 sec 
55°C 1 min 
68°C 7 min * 
Table 3.7. PCR program for site-direct mutagenesis. * The time was calculated considering about 1 
min/Kb of plasmid length. 
10 U of DpnI restriction enzyme were added directly to each amplification reaction 
and incubated at 37°C for 1 h. XL-1 Blue competent cells (Agilent Technologies) were 
transformed with DpnI treated samples and plated on ampicillin (100 µg/ml) LB plates. 
Positive colonies were inoculated in LB supplemented with ampicillin and used for 
plasmid preparation using Nucleospin Plasmid kit (Macherey-Nagel). The purified 
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plasmids were sequenced by BMR-genomics.  
Plasmids containing the correct mutation were transformed into chemical competent 
E. coli SHuffle by heat shock. Plates were incubated for 18 h at 37°C before individual 
colonies were used to small scale expression test, following the protocol reported above for 
the other grapevine DEFLs. Pelleted cells from 3 l of bacterial cultures, able to express the 
recombinant soluble mutated protein, were resuspended in lysis buffer (50 mM Tris-HCl, 
500 mM NaCl, 20 mM imidazole, 50 mM glycine, 20% (v/v) glycerol, pH 8) and lysed by 
sonicator (Bandelin Sonopul). Lysates were centrifuged at 18000 g for 30 min and the 
filtered (0.45 µm) supernatants were applied to pre-equilibrated 5 ml Ni2+-IMAC columns 
(GE Healthcare) and proteins were eluted by imidazole gradient. Fractions containing 
fusion mutated protein were pooled, concentrated and dialyzed overnight against 20 mM 
HEPES, 150 mM NaCl, pH 7.5. The MBP-6xHis tag was removed by digestion with 3C 
protease (12 μg/mg of fusion protein) overnight at 4°C and injected onto a Superdex 75 
column Hiload 16/60 (GE Healthcare) pre-equilibrated with 20 mM HEPES, 150 mM 
NaCl, pH 7.5. The fractions containing protein were pooled, concentrated and their purity 
was confirmed by SDS-PAGE gel. Proteins were quantified by their absorbance at 280 nm 
using the corresponding calculated ε (Protparam_http://web.expasy.org/protparam). 
The purified mutants (W30A, L42S, S48F, S48K and R50Q) were tested for their 
ability to induce membrane permabilization in B. cinerea using the SYTOX green assay 
reported for DEFL 13. 
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4 RESULTS 
4.1 Gene expression, antimicrobial activity and membrane 
interaction of the peach (Prunus persica) defensin PpDFN1 
4.1.1 BLAST search of peach DEFLs 
A BLAST search against the peach genome predicted peptides V 1.0 
(http://www.rosaceae.org) using PpDFN1 as query, yielded seven sequences encoding for 
similar DEFLs (Figure 4.1). The corresponding genes have the conventional defensin 
structure with two exons separated by one intron. With exception of ppa013508, which 
lacks the signal peptide, they encode for DEFL precursor proteins with a typical signal 
peptide for extracellular localization followed by the mature peptide. The mature peptides 
are about 50 amino acids long and contain the DEFL hallmarks: eight conserved cysteines, 
CSαβ motif and γ-core signature (Figure 4.1). The identified mature peptides display a 
significant sequence identity with PpDFN1, ranging from 62% (ppa21088) to 72% 
(ppa16594). Based on the identity percentage, two groups of sequence can be identified: 
one comprises the peptide predictions ppa025677, ppa023476, ppa021088, ppa014119 and 
ppa019504, the other one comprises PpDFN1, ppa013508 and ppa016594 (Figure 4.1). 
Interestingly, as reported in the database, the first group are encoded by genes mapping on 
chromosome 7 of the peach genome and the DEFL sequences encoding the second group 
(including PpDFN1) cluster together on chromosome 1, suggesting that they have 
originated by recent local duplication events. 
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Figure 4.1 Multiple sequence alignment of peach DEFLs. Alignments were performed with CLUSTAL X. 
The signal peptides, the CSαβ motif and γ-core structural signature are highlighted. The conserved Cys 
residues are indicated by grey dots. 
4.1.2 RT- qPCR analysis of Ppdfn1 gene expression 
The level of Ppdfn1 transcript was quantified by qPCR in different tissues (leaves, 
flowers and fruits at different ripening stages). Ppdfn1 transcript was always detectable by 
qPCR, suggesting a basal level of expression for this gene in all tissues. On the other hand, 
in flower, the gene expression of Ppdfn1 was much higher than in the other tissues. This 
was calculated to be 4 times higher than in leaf and up to 33 times higher than in fruit at S1 
ripening stage (Figure 4.2). In peach fruit, the Ppdfn1 expression level does not vary 
during the early stages of ripening (S1 and S2) but drastically decreases from the pit 
hardening stage (the end of S2 phase) until the full ripeness (S4, climateric phase) (Figure 
4.2). The inducibility of Ppdfn1 upon pathogen infection was assayed in artificially 
inoculated peach fruits at S3 ripening stage with Monilinia laxa fungal pathogen. By 
comparing the level of Ppdfn1 transcript in fungal and in mock infected fruits at 24 and 48 
h post-inoculation, no significant variations were detected (data not shown), suggesting 
that the expression of this gene is not induced by this pathogen. 
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Figure 4.2 Expression level of Ppdfn1 in flowers (Fl), leaves (L) and fruits at different ripening stages 
(Fr-S1, Fr-S2, Fr-S3 and Fr-S4). The small box is a zoomed view of the gene expression in S1-S4 fruits. 
Relative quantity of Ppdfn1 target cDNA was normalized to the quantity of actin cDNA. Three replicates of 
each cDNA were synthesized from three different RNA extractions. 
4.1.3 Cloning, expression and purification of PpDFN1 
Mature PpDFN1 peptide, depleted of the predicted signal peptide, was produced as 
recombinant protein in E. coli Origami strain. This strain was selected for its ability to 
enhance the disulphide bond formation in the E. coli cytoplasm and is ideal for use with 
pET 32 vector, since the thioredoxin fusion tag further enhances the disulphide bonds 
formation. Recombinant protein was not expressed when Ppdfn1 gene was cloned in 
pHAT plasmid, suitable for 6xHis fusion proteins (3 hours at 37°C or overnight at 20°C). 
On the other hand, cells transformed with recombinant pET32 vectors were able to express 
the fusion protein (TRX-6xHIS-PpDFN1). The fusion protein was expressed both also 
37°C but at 20°C protein was expressed in higher quantity and solubility. After Ni
2+
NTA 
affinity chromatography the fusion protein was digested with enterokinase proteinase and 
purified to homogeneity by cationic exchange chromatography (MONO-S) (Figure 4.3). 
The final yield was about 0.5 mg/l
 
of bacterial culture.  
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Figure 4.3 SDS-PAGE of PpDFN1 expressed from E.coli. M Protein marker; 1 soluble fraction of lysate 
E. coli cells transformed with pET32-Ppdfn1 and induced by IPTG; 2 insoluble fraction of lysate E.coli cells 
transformed with pET32-Ppdfn1 and induced by IPTG; 3 Ni2+NTA column flow through; 4 and 5 20 mM of 
Imidazole column washes; 6 TRX-6xHis-PpDFN1 fractions eluted with 200 mM Imidazole; 7 soluble 
fractions after enterokinase cleavage; 8 MONO-S fraction of pure PpDFN1.  
4.1.4 Antimicrobial activity of recombinant PpDFN1 
Purified recombinant protein was used to test its antimicrobial activity against three 
fungi: M. laxa, Botrytis cinerea and Penicillium expansum. PpDFN1 antifungal activity 
was assayed by incubating fungal conidia with different concentration of the peptide and 
measuring the spectrophotometric absorbance of the fungal mass after 24, 48 and 72 h of 
incubation. PpDFN1 displayed a clear inhibitory effect on the growth of all three tested 
fungi. The strongest activity was shown against P. expansum: addition of 10 µg/ml of 
PpDFN1 lead to more than 90 % inhibition of P. expansum and about 74 % and 31 % 
inhibition of M. laxa and B. cinerea respectively (Figure 4.4). Consistently, the calculated 
IC50 values for PpDFN1 activity were 1.1, 15.1 and 9.9 µg/ml for P. expansum, M. laxa 
and B. cinerea respectively (Table 4.1). The microscopical analysis of treated fungi with 
PpDFN1 (data not shown) confirmed the lack of morphological alterations in fungal 
hyphae, as previously reported by Wisniewski (Wisniewski ME et al. 2003), classifying 
PpDFN1 as non morphogenic defensin. 
36 
 
 
Figure 4.4 Dose-response curves of PpDFN1 for B. cinerea, M. laxa and P. expansum. 
Spectrophotometric readings of B. cinerea, P. expansum and M. laxa mycelial growth were taken after 72 h 
of incubation with 0-40 μg/ml of purified PpDFN1 at 20°C. The data are represented as a percentage of 
fungal growth as compared to the untreated control reaction with no peptide. Each data represents the 
average of three determinations ± standard error. 
fungus IC50 (µg/ml) 
B. cinerea 15.1 
P. expansum 1.1 
M. laxa 9.9 
Table 4.1 IC50 values of the inhibition of the germination of P. expansum, B. cinerea and M.laxa 
conidia by PpDFN1. 
PpDFN1 did not exhibit antimicrobial activity (IC50 > 100 μg/ml) against bacterial 
plant pathogens, such as Xanthomonas campestris, Psedumonas auroginosa, and 
Agrobacterium tumefaciens, nor against the human pathogens Listeria monocitogenes and 
Salmonella enteritidsi. Similarly, no inhibitor effect was detected against the yeast 
Saccharomyces cerevisae (data not shown). Furthermore, toxicity of PpDFN1 against 
mammals was investigated through in vitro test against human erythrocyte, showing that 
the peptide did not display any haemolytic action (data not shown). 
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4.1.5 Fluorescence microscopy analysis 
In order to determinate if the PpDFN1 antifungal activity involves fungal membrane 
permeabilization, a SYTOX green assay was performed on the sensitive fungi. When 
membranes are destabilized, this dye enters the cells and, upon binding to DNA, increases 
its fluorescence. PpDFN1 clearly induced SYTOX green uptake in B. cinerea and M. laxa 
cells where, after 6 h of protein incubation, nuclei become highly fluorescent (Figure 4.5). 
On the other hand, at the same condition, the degree of SYTOX green uptake in P. 
expansum cells appears much weaker. Despite the fluorescence microscopy analysis can 
not be considered a quantitative assay, this result suggests a lower degree of membrane 
destabilization in P. expansum. 
 
Figure 4.5 SYTOX green uptake by fungal hyphae treated with PpDFN1. Fungal hyphae of B. cinerea (a 
and d), P. expansum (b and e) and M. laxa (c and f), were incubated with 1µM of SYTOX green and 40 
µg/ml of PpDFN1. Bright field images (a, b, c) and fluorescence microscopy images (d, e, f). The results of 
membrane permeabilization are representative of one triplicate experiment. Bar= 50µm 
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4.1.6 Monolayer measurements 
PpDFN1 localized on the surface of treated fungal hyphae, as shown by our 
collaborators of Institute of Biophysical (CNR, Trento Italy) with confocal experiments 
and FITC-labeled PpDFN1 (Nanni V and Zanetti M et al. paper submitted). Considering 
that PpDFN1 stays localized for hours on the surface of fungi and causes membrane 
permeabilization, we decided to investigate the interaction between the peptide and the 
lipids by Langmuir monolayer technique. Lipid films, generated both with commercial 
lipids and lipids extracted from M. laxa, B. cinerea and P. expansum were assayed. The 
ability of PpDFN1 to insert into lipid films is dependent on the film lipid composition 
(Figure 4.6): PpDFN1 does not insert into pure egg-phosphatidylcholine (ePC) 
monolayers, nor into films obtained with lipids extracted from human erythrocytes (RBC, 
red blood cell), in accordance with hemolytic tests. However, when ceramide β-D-
galactoside, a component of glycosphingolipid family, is added to the ePC lipid film, an 
increase in surface pressure is measured. The highest rate of the surface pressure increase 
was obtained with lipids extracted from fungi, indicating the PpDFN1 preference for these 
natural lipids. Interestingly, PpDFN1-lipids binding well correlated with the calculated 
IC50 values, with the strongest interaction shown for P. expanusm. 
 
Figure 4.6 Titration measurements on different lipid monolayers. Monolayers were composed of: egg-
phosphatidylcholine (ePC); ePC and ceramide β-D-galactoside in 2% molar ratio (ePC:cer); total lipids 
extract of P. expansum (P); total lipid extract of M. laxa (M); total lipid extract of B. cinerea (B); total lipid 
extract of human red blood cells (RBC). The initial pressure was set up at 20 mN/m in 10 mM Hepes, 50 mM 
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KCl, 0.1 mM EDTA, pH 7. The surface pressure π of the lipid monolayer is defined as the decrease in 
surface tension γ, i.e., π = ( γo- γm) , where γm and  γo represent the surface tension of the water/air interface in 
the presence or absence of the lipid monolayer. 
4.2 Identification and characterization of the defensin-like 
gene family in grape (Vitis vinifera) 
4.2.1 Genome identification of DEFL sequences and analysis of their 
primary structure  
A screening of the Vitis vinifera genome, carried out in the laboratory of Dr. Claudio 
Moser at IASMA (Research and Innovation Center, Edmund Mach Foundation, San 
Michele all’Adige, Trento. Italy), lead to the identification of 79 DEFL sequences, which 
were numbered from 1 to 79 (Giacomelli et al. paper submitted). They consist of 46 genes 
and/or allelic variants, 9 likely pseudogenes and 24 gene fragments. Considering their 
cysteine signatures, the encoded grape DEFLs were separeted in four groups as shown in 
Figure 4.7. Although the sequences included in group 1 and 3 share low intra-group 
similarity, they all share a conserved pattern of cysteine residues. On the contrary, 
sequences of group 2 are extremely conserved and they are the most abundant. The other 
identified DEFLs are highly heterogeneous and, with exclusion of the CSαβ motif, lack 
any peculiar cysteine hallmark arrangement. They were all grouped in a fourth additional 
DEFL group.  
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Figure 4.7 Multiple sequence alignments of grapevine DEFLs according to their cysteine signature. 
Sequence have been classified in three groups according to the specific cysteine pattern. The additional group 
includes all other DEFLs which are not comprised in group 1, 2 or 3. The position of conserved cysteine is 
indicated by small circles above the alignments. Uncertain amino acids are indicated by x. Sequence 
similarity is highlighted by different grey tonalities, lighter for low similarity up to black for aminoacid 
identity. The signal peptide as predicted with signalP is indicated in bold.  
All sequences in group 1, with the exception of gene fragments, translate into 
peptides containing the distinctive CSαβ motif , γ-core signature and the predicted signal 
peptide positioned at their N-terminus. These sequences display a number of cysteine 
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residues in the mature protein varying from eight to ten, and a CX3-14CX4-5CX3CX8-11CX5-
10CCC pattern. Group 2 includes 13 translated DEFL gene sequences. These consist of 
highly conserved basic peptides, containing nine or ten cysteine residues arranged in CSαβ 
and γ-core motif. All DEFL peptides included in this group share a typical cysteine pattern 
CCX8CX12-13CX3CX3CX5CX8-9CHCYC, with the exception of DEFL 18 and 67, lacking 
the last cysteine residue. Group 3 collects sequences displaying the conserved cysteine 
pattern CX5-10CX4-6CX3CX9-15CX5-12CXCX3C all containing the CSαβ signature. Group 3 
includes the Vitis vinifera Antimicrobial peptide 1 (Vv-Amp1) (de Beer A and Vivier MA 
2008), which is the only grapevine defensin gene characterized so far. Finally, nine DEFLs 
genes and 11 fragments were ascribed to the additional group (group 4) 
4.2.2 Selection of grape DEFLs, recombinant expression, purification 
and antimicrobial activity 
The genomic structure and organization of DEFL gene family was known only for 
herbaceous species, such as Arabidopsis thaliana, Medicago truncatula and Oryza sativa; 
Vitis vinifera is the first (and so far the only one) woody plant species for which this 
knowledge has been achieved. Before this study, only the defensin VvAMP1 has been 
characterized in this species (de Beer A and Vivier MA 2008).  
During the course of this PhD work, the grapevine DEFL gene family was studied 
also at the transcriptome level by the laboratory of Dr. Moser (Giacomelli L et al. paper 
submitted). The expression of the 46 identified DEFL genes was evaluated by RT-qPCR 
indicating that many of grapevine DEFL genes were specifically expressed in different 
tissues and at different stages, for examples the expression of DEFL 31, 61 and 71 is 
detectable only in immature seeds and DEFL 59 and group 2 appeared to be predominant 
expressed in inflorescence tissue. In order to elucidate the possible role of DEFLs, 
Giacomelli L et al. (paper submitted ) investigated also the expression induction upon B. 
cinerea infection. Some DEFL genes resulted up regulated in challenged fruits and 
inflorescences. On the basis of these results we decided to characterize the activity of some 
grapevine DEFL proteins. DEFL candidates were selected with the intention to have 
representative sequence of each group (1-2-3), possibly expressed with a different pattern. 
Upon these considerations, the sequences encoding for the mature forms of DEFL 1 (group 
1), 13 (group 2), 22, 31 and 59 (group 3) were selected for heterologous expression (Table 
4.2).  
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DEFL GROUP 
DEFL expression in grapevine tissues Mature peptide 
S I I + B. cinerea F MW pI 
1 1 X X   5037,80 8,20 
13 2   X  6242,2 8,38 
22 3    X 5355,0 9,37 
31 3 X    5400,3 5,01 
59 3  X   4297,1 8,19 
 
Table 4.2 Gene expression of DEFL 1, 13, 22, 31, and 59, and molecular weight and isoelectric point of 
the encoded DEFL products. Seed (S), inflorescence (I), I + B. cinerea  (inflorescence upon artificial B. 
cinerea infection) and fruit (F) are the tissues where the gene expression was evaluated by RT-Real Time 
PCR (Giacomelli et al. paper submitted). MW=molecular weight, pI=isoelectric point. These parameters 
were calculated using Protparam (http://web.expasy.org/protparam).  
Different expression plasmids were used to test expression and solubility of these 
DEFLs (Table 4.3). In general, the expression of grapevine DEFLs was feasible only as 
fusion form of thioredoxin (in plasmid pET32) for VvAMP1, or maltose binding protein 
(in plasmid pOPIN M) for the other DEFLs. Expression and solubility yields were higher 
when carried out at 20°C overnight. Recombinant expression was never obtained for the 
DEFL 1 in any of tested conditions, therefore no members of group 1 DEFL were 
obtained. 
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DEFL Vector Expression conditions 
Protein 
expression 
Protein solubility 
1 
pOPIN F 
37°C x 3 hours X  
20°C overnight X  
pOPIN M 
37°C x 3 hours X  
20°C overnight X  
13 
pOPIN F 
37°C x 3 hours X  
20°C overnight X  
pOPIN M 
37°C x 3 hours √ yes 
20°C overnight √ √ yes 
22 
pHAT 
37°C x 3 hours X  
20°C overnight X  
pET32 
37°C x 3 hours √ yes 
20°C overnight √ √ yes 
31 
pOPIN F 
37°C x 3 hours X  
20°C overnight X  
pOPIN M 
37°C x 3 hours √ yes 
20°C overnight √ √ yes 
59 
pOPIN F 
37°C x 3 hours X  
20°C overnight X  
pOPIN M 
37°C x 3 hours √ yes 
20°C overnight √ √ yes 
Table 4.3 Expression screening of selected grapevine DEFLs. All tested vectors express for 6xHis fusion 
proteins at the N-terminus.  The DEFL 22 (VvAMP1) cDNA was cloned in the vectors pHAT and pET32. 
pET32 encodes 6xHis and thioredoxin (TRX) tag. The DEFLs 1, 13, 31 and 59 were cloned in the vectors 
pOPIN F and pOPIN M. pOPIN M expresses for protein fused to maltose binding protein (MBP). Expression 
conditions = condition of protein expression upon IPTG induction. Protein expression = protein expression as 
observed by the band intensity in SDS-PAGE gel; lack of expression is indicated by an X, expression by a √ 
and major expression by √ √. Protein solubility = “yes” indicates the presence of the protein in the soluble 
fraction of E. coli upon cell lyses and centrifugation (determined by SDS-PAGE gel). 
After affinity chromatography the fusion proteins were digested with enterokinase 
peptidase (for DEFL 22) or 3C protease (for DEFL 13, 31 and 59) and purified to 
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homogeneity by size exclusion chromatography (Figure 4.8). For all DEFLs, the final yield 
was about 0.2 mg/l of bacterial culture. 
 
Figure 4.8 SDS-PAGE and size exclusion chromatography of DEFL 13 (A) SDS-PAGE; 1 protein 
marker; 2 E. coli BL21 transformed with pOPINM-DEFL 13 vector not induced (negative control); 3 Total 
and 4 soluble fraction of E. coli lysate trasformed with pOPINM-DEFL 13 vector induced by 0.4 mM of 
IPTG; 5 MBP-6xHis-DEFL 13 after affinity chromatography; 6 MBP-6xHis-DEFL 13 after 3C protease 
cleavage; 7 protein marker; 8 protein marker; 9 fraction eluted from size exclusion chromatography 
corresponding to the MBP-6xHis and 10 DEFL 13. (B) Chromatogram of size exclusion protein 
purification. In the y axis is reported the mAU at 280 nm and in the x axis the volume of elution. The 
recombinant DEFLs eluted at about 90 ml volume in Superdex 75 -16/60 column. Similar results were 
obtained for the other DEFLs. 
The Ellman’s test performed for the purified DEFLs 13, 22, 31 and 59 indicated the 
absence of free thiol groups, supporting the hypothesis that all cysteines in the primary 
sequences are engaged in disulphide bridges. 
The chromatography techniques to purify grapevine DEFLs were performed in the 
biochemistry laboratory of Dr. Mark Banfield (John Innes Centre, Norwich. UK). 
The purified recombinant DEFLs were tested for their antimicrobial activity against 
the causal agent of grey rot, Botrytis cinerea. The in vitro test was conducted incubating B. 
cinerea conidia with different concentration of DEFLs and observing the germination by 
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microscopy analysis. The IC50 values were calculated by spectrophotometric 
measurements. The microscope analysis of B. cinerea conidia showed that all recombinant 
DEFLs (13, 22, 31 and 59) significantly inhibited conidia germination with a different 
intensity. The mycelium showed no apparent alteration in hyphal morphology with respect 
to the untreated fungal culture (Figure 4.9). The IC50 values of 13, 22, 31 and 59 DEFLs 
were 5.3, 14.0, 30.4 and 50 μg/ml respectively (Table 4.3), indicating DEFL 13 as the 
strongest inhibitor. The IC50 value for DEFL 22 (previously named VvAMP1) was in the 
same order of magnitude previously reported by de Beer A and Vivier MA (de Beer A and 
Vivier MA 2008). When the same experiment was repeated using a reduced and alkylated 
form of the recombinant proteins, no significant differences in fungal growth, compared to 
the negative control, were observed (Figure 4.9). This indicates that the antimicrobial 
activity is strictly dependent on the oxidized form of the protein and that the intra-
molecular disulphide bridges play a crucial role for the protein activity. 
(B) DEFL-22 (VvAMP1) (C) DEFL-31(A) DEFL-13
(E) Reduced DEFL-13(D) DEFL-59 (F) Protein buffer
 
Figure 4.9 Effect of the recombinant grapevine DEFLs on B. cinerea conidia germination. Inhibition of 
B. cinerea conidia germination by (A) 50 µg/ml of DEFL 13, (B) 50 µg/ml of DEFL 22 (VvAMP1), (C) 50 
µg/ml of DEFL 31, (D) 50 µg/ml of DEFL 59, (E) 50 µg/ml of reduced and alkylated DEFL 13 (similar 
results were obtained for the reduced and alkylated DEFL 22, 31 and  59) and (F) Protein buffer used as 
negative control. Bar = 100 μm 
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DEFL IC50 (µg/ml) 
13 5.3 
22 14.0 
31 30.4 
59 50.0 
Table 4.3 IC50 values calculated for the different grapevine DEFLs inhibitory activity on the 
germination of B. cinerea conidia.  
4.3 Characterization of the antimicrobial activity of DEFL 13 
from Vitis Vinifera  
DEFL 13 was chosen in order to investigate on its antimicrobial activity, since 
displayed the lowest IC50 value against B. cinerea among the studied DEFLs. This one, as 
all group 2 DEFL, shows a different cysteine pattern compared to the one contained in the 
other plant defensins so far characterized.  
4.3.1 Optimization of recombinant DEFL 13 expression and 
purification 
With the aim to increase the yield of pure DEFL 13 obtained from E. coli expression,  
different expression, purification strategies and protocols were tried. Indeed, while the 
fusion protein form of MBP-6xHis-DEFL 13 in E. coli was produced with an yield of 
about 10 mg/l of bacterial culture, final yield in pure native DEFL 13 was only 0.2 mg/l of 
bacterial culture, indicating that much of the protein product was lost during purification 
after protein cleavage. 
The recombinant expression in a eukaryotic host was tried in order to facilitate the 
formation of disulphide bridges, predicted to be 5 in a 57 amino acids-long peptide. The 
yeast Pichia pastoris was chosen. Ten different colonies of P. pastoris transformed with 
pPICZα-DEFL 13 were screened and no colony appeared to express protein in the 
extracellular environment nor in the cytoplasm. This was confirmed by SDS gel stained 
with InVision™ His-tag In-gel Stain, a fluorescent stain formulated for sensitive and 
specific detection of His-tagged fusion proteins. 
In attempt to increase the protein production in E. coli system, the E. coli SHuffle 
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strain was shown to be a valid alternative to BL21 Origami strain, since the final yield in 
pure DEFL 13 was about 0.5 mg/l. (Table 4.4). SHuffle is an engineered E. coli strain 
capable of expressing, in the cytoplasm, proteins with high number of disulphide bridges, 
thanks to the presence of disulphide bond isomerase (DsbC). Furthermore, DsbC act also 
as general chaperone for protein folding. Probably the ability of Origami strain cells to 
enhance the expression of proteins rich in disulphide bonds is strictly associated with the 
presence of thioredoxin as protein fusion tag. 
E.coli strain Yield for liter of bacterial culture 
BL21 Origami 0.2 mg/l 
SHuffle 0.5 mg/l 
Table 4.4 Yields in purified DEFL 13 (mg/l of bacterial culture) expressed in two different E. coli 
strains.  
Trials to improve yield were made also by changing chromatography purification 
strategies, for example using Ni
2+
NTA and amylose affinity chromatography (connected in 
series) after 3C protease cleavage (data not shown) or cation exchange chromatography, 
both instead of size exclusion as final purification step. These strategies allowed to achieve 
higher protein yield, however this was affected by lower purity level (Figure 4.10), 
unsuitable for in vitro function investigations. 
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Figure 4.10 Cationic exchange chromatography after 3C protease cleavage of MBP-6xHis-DEFL 13 
(A) Cationic exchange chromatography of DEFL 13. FT is the column flow through peak; peaks 49 and 55 
eluted respectively at 360 and 390 mM NaCl. (B) SDS page of cationic exchange chromatography. +3C, 
protein mixture after the 3C protease cleavage loaded in the SP sepharose column; FT, flow through; 49 and 
55, eluted fractions. 
4.3.2 Antimicrobial activity against fungal and bacterial pathogens 
In order to analyse the spectrum of DEFL 13 action, the protein was assayed against 
a panel of different fungal pathogens and two bacterial plant pathogens. These were 
Colletotrichum acutatum, Fusarium oxysporum, Monilinia laxa, Aspergillus niger, 
Alternaria arboresca, Penicillium expansum and Trichoderma spp.. Fungal conidia were 
incubated with 50 ug/ml of peptide and germination was analysed by microscopy after 16 h 
(Figure 4.11 (1)). The percentage of fungal growth inhibition was calculated by 
spettrophotometric reading after 48 h as reported above (Figure 4.11 (2)). At 50 ug/ml 
concentration, DEFL 13 was able to inhibit more than 90% of B. cinerea growth and the 
growth of C. acutatum, F.  oxysporum, M. laxa, A. niger, A. arboresca, P. expansum and 
Trichoderma spp. of 24.6, 22.0, 35.6, 62.7, 49.1, 10.3 and 26.8 % respectively, compared 
to untrated fungal conidia. All tested fungi did not show any morhological change respect 
to the untreated fungal hyphae, classifying the peptide as non morphogenic defensin. 
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Figure 4.11 Effect of DEFL 13 on a panel of fungi. (1) Microscopy pictures of treated and untreated 
conidia. Microscopy analysis of conidia untreated (A, C, E, G, I, M, O, Q) and treated (B, D, F, H, L, N, P, 
R) with 50 ug/ml of DEFL 13, after 16 hours of incubation. (A, B) Colletotrichum acutatum (C, D) Fusarium 
oxysporum (E, F) Monilia laxa (G, H) Aspergillus niger (I, L) Alternaria arboresca (M, N) Penicillium 
expansum (O, P) Trichoderma ssp and B cinerea (Q, R). (2) Effect of DEFL 13 on fungal biomass. 
Spectrophotometric readings were taken after 48 h and compared to the untreated control reactions with 
protein buffer. Data are represented as % of fungal growth inhibition. The experiments were repeated three 
times and the standard deviation is reported on the graph.   
(1) 
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Concentration up to 100 µg/ml of DEFL 13 did not provoke any effect on the growth 
of plant pathogenic bacteria Agrobacterium tumefaciens and Erwinia amylovora (data not 
shown). 
4.3.3 Effect of the cations on the antifungal activity 
The antifungal activity of some plant defensins is significantly reduced when the 
ionic strength of the fungal growth medium is increased. The effect of K
+
 and Mg
2+
 cations 
on the DEFL 13 antibotrytis activity was assayed by incubating B. cinerea conidia with 
different concentration of peptide (50, 25, 12.5, 6.25 and 3.13 µg/ml) in half PDB medium 
supplemented with different concentration of cations (50 mM, 25 mM and 12.5 mM for 
KCl and 5 mM, 2.5 mM and 1.25 mM for MgCl2). The ability of DEFL 13 to inhibit the 
growth of B. cinerea strongly depends on cation concentration of the medium. In KCl 
supplemented medium (Figure 4.12 A) the percentage of inhibition gradually decreases as 
the cation concentration increases, showing a cation-dose dependence effect on antifungal 
activity at all tested peptide concentrations. This dependence is lost when a low 
concentration of DEFL 13 (3.13 µg/ml) is used but probably at this concentration the 
signal : noise ratio is too low to be considered reliable, as indicated by the scarce 
reproducibility of values found across different experiments (data not shown). The addition 
of MgCl2 to the medium (Figure 4.12 B) strongly reduces the activity of the peptide: 5 mM 
of MgCl2 is sufficient to completely abolish the antifungal effect of high concentration of 
DEFL 13 (50 µg/ml). 
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Figure 4.12 Effect of different concentration of KCl (A) and MgCl2 (B) on the antifungal activity of 
DEFL 13 agaisnt B. cinerea. The % of growth inhibition and the concentration in µg/ml of DEFL 13 were 
reported in the y and x axis respectively. The different bar colors indicate the different medium as reported in 
the legend. Mean values and standard errors calculated on three replicates are reported on the graph.  
4.3.4 Thermal stability of DEFL 13 
The structural and functional stability of antimicrobial peptides at high temperatures 
is an important factor for their possible exploitation. For this reason, the thermal stability 
of DEFL 13 was assayed by circular dichroism (CD) spectroscopy. Far UV CD spectra of 
thermally treated DEFL 13 (10 min at 90°C) was compared to the one of the untreated 
DEFL 13. Furthermore, thermal treated peptide was assayed for its antifungal activity 
against B. cinerea.  
The far UV CD spectrum of DEFL 13 at room temperature showed the presence of a 
significant amount of coiled structures (Figure 4.13) as indicated by the absence of the 
typical positive signals of α-helix and β-sheet secondary structures. The result of fits 
averaging provided a secondary structure composition of 16% α-elix, 26.5 % β-strand, 14.5 
% turn and 42.9 % random coil. The spectra of untreated and thermal treated DEFL 13 did 
not display any significant difference, indicating that the secondary structure did not vary 
after a high temperature treatment (data not shown). Similarly, CD spectra did not vary 
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when the peptide was treated with DTT (dithiothreitol) reducing agent. 
 
Figure 4.13 Far-UV CD spectrum of DEFL 13. Ten spectra were accumulated from 190 to 240 nm at 0.2 
nm intervals and averaged to achieve an appropriate signal : noise ratio. The spectrum of the buffer was 
substracted. 
Furthermore, when assayed in standard antibotrytis test, thermally treated DEFL 13, 
retained 30% of activity against B. cinerea conidia germination (compared to the 94% 
activity shown by untreated protein) (Figure 4.14).  
 
Figure 4.14 Temperature effect on the antifungal activity of DEFL 13. The percentage of growth 
inhibition on B. cinerea conidia treated with 50 µg/ml boiled (90°C for 10 min) DEFL 13 compared to 
untreated peptide.  
4.3.5 Activity against fungal hyphae and protoplasts of B. cinerea 
The ability of DEFL 13 to inhibit actively growing B. cinerea mycelium was also 
tested and compared to the inhibitory effect on conidia germination. This was evaluated in 
vitro both by microscopy observation and spectrophotometric readings. The B. cinerea 
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conidia were incubated overnight in half PDB before adding 50 µg/ml of DEFL 13. After 2 
h the treated fungal hyphae showed morphological differences compared to untreated fungi 
since vacuolation appeared on the treated mycelia. (Figure 4.15). The percentage of growth 
inhibition after 48 h was calculated to be 81.5% (± 3.9), slightly less than the effect on the 
conidia germination reported above. 
 
Figure 4.15 Effect of DEFL 13 on actively growing B. cinerea. Overnight germinated conidia were treated 
with (A) protein buffer and (B) 50 μg/ml of DEFL 13 and were observed at the optical microscope after 2 h 
of incubation. Scale bar= 50 μm 
Fungal hyphae are surrounded by a cell wall that antimicrobial peptides must cross 
before reaching the plasma membrane. The effect of cell wall on the antifungal activity of 
DEFL 13 was investigated by incubating B. cinerea protoplasts with 50 µg/ml of 
recombinant peptide. After 24 h of treatment, the growth of protoplasts was inhibited of 
about 80%, compared to untreated protoplast culture (data not shown), indicating that cell 
wall is not crucial for antimicrobial activity of DEFL 13. 
4.3.6 Membrane permeabilization and localization of DEFL 13 
The effect of DEFL 13 on the fungal membrane was assayed, observing the uptake of 
the fluorescent dye SYTOX green within the treated fungal cells. DEFL 13 clearly induced 
SYTOX green uptake in B. cinerea hyphae: here, after 2 h of protein incubation, a high 
degree of fluorescence was detected (Figure 4.16). Incubation of fungal hyphae with 
protein buffer and SYTOX green did not show fluorescence uptake (data not shown). 
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Figure 4.16 SYTOX green uptake into DEFL 13 treated B. cinerea. B. cinerea germinated conidia were 
incubated with 50 µg/ml of DEFL 13 and 1µM of SYTOX green and visualized by fluorescence microscopy 
after 2 h. The results of membrane permeabilization are representative of one triplicate experiment Scale bar= 
50µm.  
The DEFL 13 localization on treated fungal hyphae was addressed. The peptide was 
labeled with FITC and labeled protein was localized on B. cinerea hyphae by fluorescence 
microscopy. As labeling could possibly have a negative effect on the activity of DEFL 13, 
the antimicrobial activity of FITC-labeled DEFL 13 was tested against B. cinerea, showing 
to be the same than the one displayed by unlabelled protein form (data not shown). B. 
cinerea hyphae were treated with 50 µg/ml of FITC-labeled DEFL 13 for 1 h and the 
localization was monitored by fluorescence microscopy. As shown in Figure 4.17 FITC-
labeled DEFL 13 appears mainly localized in the intracellular environment of B. cinerea 
treated hyphae.  
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Figure 4.17 Localization of FITC-labeled DEFL 13 B. cinerea.  Fungal hyphae of B. cinerea grown 
overnight in half PDB were treated with 50 μg/ml of FITC-labeled DEFL and after 1 h of incubation, the 
labeled peptide was detected by fluorescence microscopy. Bright field image (a) and fluorescence 
microscopy image (b). Scale bar = 50 μm 
4.3.7 Activity of DEFL 13 on B. cinerea signaling mutants 
It is reported that some plant defensins display their antimicrobial activity through 
activation of different intracellular mechanism, such ROS production, Ca
2+
 influx 
alteration or interferation with cell cycle. Considering that DEFL 13 enters to the B. 
cinerea cells we decided to perform a screening on signaling mutants of B. cinerea in order 
to investigate a possible involvement of intracellular signaling cascades in DEFL 13 
mechanism of action. The collection of mutants tested in this screening was generated by 
the group of Prof. Paul Tudzynski (University of Muenster, Germany). The mutants are 
knock-out mutants where the deletion of each target gene was performed by replacement 
vector carrying the hygromycin resistance cassette. The mutant collection includes mutants 
defective in cAMP, calcium and ROS signaling, sensore kinases and G-proteins. About 30 
% of tested mutants (reported in the Table 4.7) showed a less sensitivity to DEFL 13 
action. Decrease in sensitivity was considered significant when reached values < 60% . 
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mutated gene gene function 
Bc1g_14021 Bc- and Ss-specific ??? 
Bc1g_02686 Regulator of photolyases 
Bc1g_11672 Microsomal signal peptidase 12kD subunit 
Δbtp1 Transmembrane protein 1 (BTP1) [7-TM] 
∆bcgpr1 G protein-coupled receptor 1 
∆bcgpr3 G protein-coupled receptor 3 
∆bcg1  Gα subunit 1 (BCG1) 
∆bcg2 Gα subunit 2 (BCG2) 
∆bcg3 Gα subunit 3 (BCG3) 
∆bcgb1 Gβ subunit 1 (BcGB1) 
∆bcgg1 Gγ subunit 1 (BcGG1) 
∆bac Adenylatcyclase BAC 
Δbcatf1 ATF1 transcription factor 
Δbap1 AP1-like transcription factor 
Δbcras2 RAS-type GTPase BcRAS2 
Δbccdc42 Rho-type GTPase BcCDC42 
Δbcbem1 Scaffold protein 
Δbcfar1 Scaffold protein 
Table 4.7 Signaling B. cinerea mutants with decreased susceptibility to DEFL 13 with respect to the 
wild type fungus. DEFL 13 displayed a growth inhibition < than 60% against the reported mutants (three 
technical replicates).  
The weaker antimicrobial activity were confirmed only for Bc1g_11672 
(Microsomal signal peptidase 12kD subunit), ∆bcgpr3 (G protein-coupled receptor 3), 
Δbccdc42 (Rho-type GTPase BcCDC42) and Δbcbem1 (scaffold protein), repeating the 
test in independent assays.  
4.3.8 Polyclonal antibody against DEFL 13 
The DGRCCKDHPKLGHCVP synthetic peptide (corresponding to DEFL 13 amino 
acid position 4 - 18) was used to immunize two rabbits and produce anti-DEFL 13 
polyclonal antibody. The peptide was designed considering the prediction of antigenic 
determinants in the DEFL 13 primary sequence and the hydrophobicity of these regions. 
After Western blot titration, serum from rabbit 1 resulted more concentrated and specific 
than serum from rabbit 2 and it was selected for CNBr-sepharose affinity purification. A 
dilution 1:100 of purified antibody from serum of rabbit 1 (Figure 4.18) was used for 
Western blot analysis. 
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Figure 4.18 Western blot assay of purified DEFL 13. 
4.3.9 DEFL 13 mutagenesis 
Previous structure-function studies of cysteine-rich antimicrobial peptides from 
different organisms identified a conserved three-dimensional motif with a consensus 
sequence GXC(X3-9)C named γ-core motif (Yount NY et al. 2004). As above reported, 
DEFL 13 displays this motif, with the sequence of GLCKKLSSGRHVC and with a net 
positive charge (+3). Mutations in the primary sequence of γ-core motif altering the 
peptide cationicity and hydrophobicity were previously reported to strongly affect the 
antimicrobial function of plant defensins (Sagaram US et al. 2011). Site-directed 
mutagenesis of DEFL 13 was performed in order to investigate on the role of putative key 
residues on the DEFL 13 antifungal action. The mutations W30A, L42S, S48F, S48K and 
R50Q, mapping in the γ-core (L42S, S48F, S48K and R50Q) or in putative crucial sites for 
DEFL 13 structure (W30A) were generated (Table 4.8 and Figure 4.19)  
 
Figure 4.19 Primary sequence of DEFL 13 and site-specific mutation. The mutated amino acids are 
underlined and the substitutions are reported over them. CSαβ and γ core motifs are reported. 
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Mutant 
γ-core motif 
Comment Positive 
residues 
GRAVY 
INDEX 
Wild 
type 
+3 -0,085  
W30A   
Tryptophan was replaced with Alanine to evaluate the effect of an high hydrophobic 
and structurally important residue on the antifungal activity. 
L42S +3 -0,43 Leucine was replaced with Serine to decrease the hydrophobicity in the γ-core motif. 
S48F +3 0,192 
Serine was replaced with Phenylalanine to increase the hydrophobicity in the γ-core 
motif. 
S48K +4 -0,323 Serine was replaced with Lysine to increase the positive charge of γ-core motif. 
R50Q +2 -0,008 Arginine was replaced with Glutamine to decraese the positive charge of γ-core motif. 
Table 4.8 List of DEFL 13 mutants. The variation of γ-core motif parameters and the comment are reported 
for each mutant. For the γ-core motif, the number of positive residues and the GRAVY* were reported for 
each mutation as calculated by Protparam (http://web.expasy.org/protparam). *GRAVY (grand average 
hydrophaticity index): positive GRAVY (hydrophobic), negative GRAVY (hydrophilic) (Kyte and Doolittle, 
1982)  
All mutants were expressed in the soluble fraction of E. coli SHuffle strain and 
purified to homogeneity (Figure 4.20 a) following the same protocol used for wild type 
DEFL 13 and yielding similar protein quantity. Protein integrity and identity were assayed 
by Western Blot (Figure 4.20 b).  
 
Figure 4.20. (a) SDS-PAGE gel and (b) Western blot analyses of purified DEFL 13 and mutants. 
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The purified W30A, L42S, S48F, S48K and R50Q mutants were able to induce 
membrane permeabilization in treated fungal hypahe of B. cinerea (Figure 4.21). Despite 
this test can not be considered a quantitative assay, a visual analysis showed that the tested 
DEFL 13 mutants displayed a different level of fluorescence uptake. In particular, the 
mutants S48K caused higher permeabilization in B. cinerea hyphae and the mutant L42S 
induced weaker membrane destabilization in treated mycelium.   
 
Figure 4.21 SYTOX green uptake into B. cinerea treated with DEFL 13 and mutants (L42S, S48K, 
S48F, W30A, R50Q). B. cinerea germinated conidia were incubated with 50 µg/ml of DEFL 13 (WT), 
L42S, S48K, S48F, W30A or R50Q and 1µM of SYTOX green and visualized by fluorescence microscopy 
after 2 h. In the small box the correspondent bright field images are reported. Scale bar= 50µm.  
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5 DISCUSSION 
5.1 DEFL gene family in peach (Prunus persica) and grapevine 
(Vitis vinifera) 
In different plant species DEFL peptides were recognized to be encoded by large 
multigene families: 317 and 92 DEFL genes have been identified in the Arabidopsis 
thaliana  and Oryza sativa genomes respectively, whereas 369 DEFL EST sequences have 
been recognized in Medicago truncatula (Graham MA et al. 2004; Silverstein KA et al. 
2005; Silverstein KA et al. 2007). The recent publication of Prunus persica (released by 
the International Peach Genome Initiative, IPGI, at the Genome Database for 
Rosaceae_http://www.rosaceae.org/peach/genom) and Vitis vinifera (Velasco R et al. 
2007) genomes allowed investigation of the DEFL gene family in woody plant species. A 
BLAST search against the P. persica genome predicted peptide database, using PpDFN1 
as query (the first plant defensin identified in peach, Wisniewski ME et al. 2003), 
identified other seven sequences encoding DEFLs. A more elaborated and extensive 
screening of the peach genome, using suitable matrices such as HMM (Hidden Markov 
Model), could probably reveal a higher number of DEFL genes also for this plant species. 
This was performed for grape (V. vinifera) where the use of successive iterations of HMM 
and BLAST searches resulted in the identification of 79 DEFL grapevine sequences 
followed by the full annotation of 46 DEFL genes (Giacomelli L et al. paper submitted). 
In peach, the seven predicted DEFL peptides show high similarity with the 
previously reported PpDFN1. All of these display 8 cysteine residues, the typical CSαβ and 
γ core motifs. In grapevine, the majority of DEFL peptides display the typical defensin 
signatures: the signal peptide at the N-terminal, the CSαβ motif and the γ core motifs and 
contain 6, 8, or 10 cysteine residues in the mature protein sequence.  
The high number of DEFL genes and the low identity in their primary sequences 
suggest that divergent selection events occurred following duplication and possibly 
providing new functions for these peptides. It has been indicated that the hypothesized 
evolution events leading to the DEFL gene family differentiation is striking similar to 
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those reported for the NBS (nucleotide binding site) and LRR (leucine rich-peptide) 
families of R-genes, both found as single gene and cluster throughout plant genomes 
(Graham MA et al. 2008). These similarities are compatible with an involvement of 
DEFLs genes in defense against pathogens. 
5.2 Defensin from peach (Prunus persica): PpDFN1 
5.2.1 Gene expression, antimicrobial activity and membrane 
interaction of the peach (Prunus persica) defensin PpDFN1 
It is commonly believed that DEFL peptides act as preformed plant defence 
components in particular tissues or stages, such as dormant tissues or mychorrized roots, 
where inducible defence responses decrease. In addition to undergo a seasonal winter 
regulation in peach bark tissues, Ppdfn1 gene expression was also shown to increase in 
fruits at early ripening stages, suggesting a role for this gene in protecting the embryo 
before seed lignification (Wisniewski ME et al. 2003). Consistently, our data show that 
this gene is more expressed during S1 and S2 ripening stages, before the fruit pit hardening 
has completed. It is known that the incidence of brown rot, caused by M. laxa and 
fructigena in peach, strongly decreases for a short period during fruit ripening (Mari M et 
al. 2003), in correspondence to the pit hardening, when the level of Ppdfn1 transcript 
decreases. Since we show that recombinant PpDFN1 is able to inhibit M. laxa germination 
in vitro, it will be necessary to quantify the endogenous level of PpDFN1 in ripening fruits, 
to exclude a role for this peptide in the fruit defence against Monilia. 
Our data show that the Ppdfn1 gene expression is much higher in flower than fruit 
and leaf. Several plant DEFL genes were shown to be specifically expressed in flowers 
(Tavares LS et al. 2008), such as NaD1, a defensin from Nicotiana alata (van der Weerden 
NL et al. 2010) and PhD1 from Petunia hybrida (Janssen BJC et al. 2003). These 
defensins, and other flower DEFLs, were shown to be capable of antifungal activity against 
a broad spectrum of pathogens. Nevertheless, the flower specific DEFLs LURE 1 and 
LURE 2 from Torenia fournieri, besides being antifungal peptides, were shown to act as 
pollen attractants during plant fertilization (Okuda S et al. 2009), supporting the hypothesis 
that DEFL peptides can play additional roles during plant growth and development. 
Further studies are needed to evaluate the biological significance of Ppdfn1 expression in 
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flower.  
In order to investigate the activity of PpDFN1, the recombinant mature form of this 
peptide was overexpressed in E. coli and purified to homogeneity. The combination of E. 
coli Origami strain and pET32 expression vector was considered an efficient way to 
produce soluble recombinant protein with a high level of purity. 
The purified PpDFN1 did not display any antimicrobial activity against human and 
plant bacterial pathogens but was capable of antifungal activity against  M. laxa, P. 
expansum and B. cinerea fungi. The efficiency of PpDFN1 antifungal action depends on 
the fungal species, as shown by the calculated IC50 of 1.1, 9.9 and 15.1 µg/ml for P. 
expansum, M. laxa and B. cinerea respectively. For the majority of defensin peptides, the 
molecular mechanisms of the specificity of action are still not clear. Previous studies 
indicated that membrane destabilization is a common effect caused by these peptides in 
target cells (Thevissen K et al. 1996, van der Werdeen NL et al. 2010), suggesting that 
membrane composition of target cells could be an important determinant for the defensin 
activity. On the other hand, for some plant defensins further mechanisms were shown to 
specifically play a role. As an example NaD1, capable of membrane permeabilization in 
Neurospora crassa, was shown to enter fungal cells and induce ROS (Reactive Oxygen 
Species) production. The involvement of fungal membrane destabilization in the PpDFN1 
antifungal activity was shown by SYTOX green assay for all tested fungi. However a 
lower level of fluorescence uptake was shown for P. expansum, suggesting a weaker 
permeabilization. Considering that PpDFN1 showed the highest antifungal activity against 
P. expansum, these data point to the involvement of other mechanisms leading to the 
observed inhibition of this fungal species.  
Lipid monolayer is a simple membrane model system, that can be conveniently used 
to study the first step of membrane interaction. This system was used in order to 
investigate the possible correlation between PpDFN1 specificity and lipid membrane 
composition. Using films composed by different lipids, we obtained a qualitative analysis 
of the binding of PpDFN1 to lipids, determining its dependence on membrane 
composition. 
Previous studies showed that plant and insect defensins interact with target cell 
membranes through binding to glucosylceramides lipid component (Thevissen K et al. 
2004). Here we showed that the addition of the neutral sphingolipid ceramide β-D-
galactoside to egg-phosphatidylcholine (ePC) membrane films significantly promoted the 
PpDFN1 lipid interaction. This reinforces the hypothesis that the presence of sphingolipid 
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species in target cell membranes is crucial for defensin action, as already indicated for 
RsAFP2 and DmAMP1 (Thevissen K et al. 2004; Aerts AM et al. 2008). Besides being an 
important structural component of eukaryotic membranes, sphingolipids are also 
recognized as secondary messenger molecules regulating the equilibria between cell death 
and cell growth processes. Interaction of plant defensins with these specific lipids can 
possibly lead to activation of signaling cascades promoting fungal growth arrest 
(Thevissen K et al. 2006). 
Nevertheless, when films were made with lipid extracted directly from fungi, 
PpDFN1 bound to monolayer with higher affinity, suggesting that additional lipid 
components of fungal membranes play a role in this interaction. These could be the net 
negative charges of the fungal lipid extract (as inferred by the Zeta-potential measurements 
-data not shown-), electrostatically driving the positively charged defensin on the 
membrane, or other lipid species present in fungal membranes. These components are 
likely involved in the PpDFN1 specificity, as shown by the strong correlation between 
IC50 values and the monolayer measurements. Further investigations will be necessary to 
reveal the nature of the membrane components playing a role in this interaction and 
possibly to elucidate the molecular mechanisms of PpDFN1 antifungal activity. 
5.3 Grapevine DEFLs  
5.3.1 Recombinant expression and antimicrobial activity of grapevine 
(Vitis vinifera) DEFLs.  
The identified grapevine DEFLs (Giacomelli L et al. paper submitted) sharing a 
common cysteine pattern were classified in three main groups(1, 2 and 3) and the 
remaining DEFLs were collected in a fourth additional group. The encoded DEFLs 
belonging to group 3 show the cysteine pattern previously reported for defensins identified 
in other plant species and for VvAMP1 (the only DEFL from grapevine previously 
known). On the contrary, the grapevine DEFLs belonging to the group 1 and 2 show a 
different cysteine pattern with respect to the plant defensins characterized until now. 
In order to test the antimicrobial activity of grapevine DEFLs, DEFL 1, 13, 22, 31 
and 59 were selected, since they belong to different groups (1, 2 and 3) and display a 
different tissue specificity or B. cinerea inducibility. Recombinant expression of DEFL 1, 
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belonging to group 1, failed and for this reason no members of group 1 were tested for 
their antimicrobial activity. The other selected DEFLs were successfully expressed only as 
protein fused to thioredoxin (TRX) or maltose binding protein (MBP) in Escherichia coli. 
In general, the presence of fusion tags at the N-terminal of the protein facilitates the 
expression in E. coli of proteins with a predicted complex folding, such as defensins. Until 
now, only PDC1 a plant defensin from corn (Kant P et al. 2009) was expressed without 
fusion tags in the soluble fraction of E. coli, as biological active peptide. 
Several plant defensins were reported to inhibit the growth of B. cinerea with 
different efficiency. For examples DmAMP2 (a defensin from Dhalia meckii), HsAFP1 (a 
defensin from Heuchera sanguine) and RsAFP2 (a defensin from Raphanus sativus) 
showed IC50 values of 12, 10 and 6 μg/m1 respectively (Osborn et al. 1995).  
All tested recombinant grapevine DEFLs are capable of inhibiting B. cinerea conidia 
germination. The most active protein (DEFL 13) is encoded by the DEFL 13 gene, which 
was highly induced upon B. cinerea infection. The reported gene expression pattern and 
the antimicrobial activity in vitro suggest a defense role for DEFL 13 in planta.  
The antifungal activity of the other tested DEFLs (22, 31 and 59) should be tested 
against a broader range of pathogens, in order to determine whether their weak effect 
against B. cinerea reflects a different biological role in planta. Since DEFL 59 and its more 
active partner DEFL 13 are both inflorescence specific, a different target or function would 
also justify their specific concomitant expression.  
The loss of antibotrytis activity that follows the reduction and alkylation of DEFLs 
13, 22, 31 and 59 indicates that, for these peptides, the disulphide bridges are necessary for 
the activity and their tertiary structure is crucial for antimicrobial activity. Similar results 
were obtained for NaD1 (a defensin from Nicotiana alata), where the disruption of its 
disulphide bonds resulted in the loss of antifungal activity (van der Weerden NL et al. 
2008). On the other hand, oxidized species of human defensins 3 displayed the same 
antifungal potency (Wu Z et al. 2003) as the reduced one, indicating a dispensable role of 
corrected disulphide bridges for this peptide. None of the tested DEFLs display a 
morphogenetic action on the treated fungal mycelium. Indeed, in addition to the growth 
inhibitory activity, some defensin peptides (such as the Rs-AFP2 and the Hs-AFP1) are 
capable of hyphae swelling and hyperbranching on fungal target (Osborn et al. 1995). It 
was reported that the capacity to induce morphological effect on target fungi is not a 
specific characteristic of the protein but depends on the fungal target. The molecular 
mechanisms regulating the morphogenic action are still unknown. 
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5.3.2 DEFL 13 
DEFL 13 has been selected for further analyses among the four above reported 
grapevine DEFLs for the following reasons: 
(a) the strongest antimicrobial activity against B. cinerea,as indicated by the reported 
IC 50 values 
B. cinerea, the grey mold fungus, infects more than 200 plant species and it is one of 
the most important grape pathogen. Plant diseases caused by B. cinerea are mainly 
characterized by rapid maceration of the plant tissue and massive production of conidia 
that can further distributed by wind, rain or insects (van Kan 2006). The inhibition of 
conidia germination is a crucial step for controlling and preventing the infection of the host 
plant and the discovery of antimicrobial peptides with a strong ability to inhibit the conidia 
germination is highly interesting for the plant protection.    
(b) the original cysteine pattern in the primary sequence  
DEFL 13 shows an interesting cysteine pattern in the primary sequence (CCX8CX12-
13CX3CX3CX5CX8-9CXCXC) with ten cysteine residues all engaged in disulphide bridges 
as shown by the Ellman’s test. PhD1, a defensin from Petunia hybrida, also displays 10 
cysteine residues in the primary sequence but with a different arrangement (Janssen BJ et 
al. 2003). 
5.3.2.1 DEFL 13 purification 
In the past several defensins were purified directly from the tissue where they 
resulted mainly expressed, for examples the defensin from Phaseolus vulgaris was directly 
purified from purple beans with a high yield (43 mg of purified defensin for 500 g of 
beans) (Wu X et al. 2011). However, not all defensins are necessarily present in high 
quantity and not always the protein purification from tissues, were the defensins are largely 
expressed, is easy to obtain (for example mature seeds of fruit where purification processes 
are difficult, due to lignification and oil content). In addition, different plant defensins are 
often expressed in the same tissue and the purification of a specific peptide is very difficult 
to obtain, due to the similar biochemical features shared by these peptides.  
DEFL 13 gene is highly expressed in inflorescence but the presence of other DEFL 
transcripts (such as DEFL 1, 2 and 59) makes DEFL 13 extraction from this tissue not 
suitable.  
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The expression of recombinant forms of proteins in heterologous systems is a direct 
and fairly simple way to overcome these problems. The production of plant defensins in 
heterologous system has widely been performed, in particular using E. coli (Figure 5.1).  
  
 
Figure 5.1 Representation of the different strategies used for plant defensins production/isolation. The 
percentages were determinated evaluating the production of 49 plant defensins.   
It is known that lack of expression of eukaryotic proteins in prokaryotic organism is 
often due to the complexity of eukaryotic proteins respect to prokaryotic ones. Despite the 
small size and the simple structure of defensin proteins, the presence of several disulphide 
bridges, necessary to the protein stability, may impair the expression yield in E. coli. For 
this reason, protein expression in yeast were performed for several plant defensins, giving 
higher yields. However our attempts to produce DEFL 13 as recombinant protein in P. 
pastoris failed, indicating that folding process is not the only cause of low protein yield. 
On the other hand the use of a different E. coli strain, specialized in disulphide bridge 
production, allowed significant improvement in DEFL 13 yield.  
Furthermore for DEFL 13 and in general for the plant defensins tested in this PhD 
work, the choice of the expression vector has been crucial for the protein production. 
Tested DEFLs were successfully expressed when fused to TRX or MBP proteins and not 
when produced only with HIS-tag, consistently to the majority of plant defensins reported 
until now. Indeed, the presence of protein fusion partners can help to keep protein soluble 
during folding and to protect them from protein degradation by bacterial protease. 
During protein purification it was observed a high leakage of proteins: the yield in 
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MBP-6xHis-DEFL 13 in E. coli lysate suspension was calculated to be about 20 times 
higher than the final yield in purified DEFL 13. High protein losses were associated with 
the steps of protein concentration and dialysis, suggesting that the high positive charge of 
DEFL 13 could be responsible for unspecific binding with membranes. A slight 
improvement has been achieved by performing protein chromatography in columns 
connected in series, avoiding buffer change and concentration step.  
5.3.2.2 Antimicrobial activity of DEFL 13 
The antimicrobial action of DEFL 13 has been tested against different fungal 
pathogens and two bacteria attacking several plant crops. DEFL 13 did not display 
antimicrobial activity against the tested bacterial plant pathogens, consistently with the 
majority of plant defensins so far characterized. The concentration of DEFL 13 able to 
inhibit more than 90% of B. cinerea conidia germination had a weak effect on the other 
tested fungi (less than the 50%), with the exception of A. niger (62% values of fungal 
inhibition). This difference in antifungal potency is quite unusual among plant DEFLs, 
which normally display a broad range of antimicrobial activity against fungi. For examples 
Ah-AMP1, Ct-AMP1, Dm-AMP1, Hs-AFp1 and Rs-AFP2 showed a similar strong 
antifungal activity against B. cinerea, Cladosporium sphaerospermum, Fusarium 
culmorum, Leptosphaeria maculans, Penicillium digitatum and Verticilium albo-atrum. 
Also PpDFN1 (as reported above in this thesis) is highly active against all three tested 
fungi (M. laxa, P. expansum and B. cinerea). The molecular bases of DEFL 13 specificity 
are currently ignored. Possibly, a specific receptor in the cell membrane or a specific 
intracellular target in B. cinerea cytoplasm could be involved. 
Cation sensitivity has been widely described for many basic antimicrobial peptides, 
which act via electrostatic interactions. Several works reported about the antagonist effect 
of cations on the antimicrobial activity of plant defensins (Terras FRG et al. 1992). It is 
commonly accepted that this reduction of activity is caused by an antagonist effect on the 
interaction of peptides with negative charged fungal membranes. De Samblanx and co-
workers (De Samblax GW et al. 1997) suggested a model to explain this effect, where both 
ionic and non-ionic stereospecific interactions are involved in defensin action. The ionic 
components of the interaction are strongly affected by the ionic strength of the medium, 
instead the non ionic ones are cation-resistant, suggesting a putative receptor interaction. 
Furthermore, Thevissen and co-workers (Thevissen K et al. 1999) reported about the 
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dependence of membrane permeabilization on the cation composition of the medium, 
suggesting two different mechanisms of action: (i) a binding-site-mediated membrane 
insertion, not highly influenced by the presence of cations, and (ii) a binding-site-
independent membrane insertion that is totally affected by ionic strength of the medium 
and involves only electrostatic interactions. The antimicrobial activity of DEFL 13 results 
strongly dependent on the ionic strength of the medium, in particular when divalent cations 
are added. The antifungal activity is reduced proportionally to the increase of cation 
concentration, with a complete abolishment of DEFL 13 activity at 5 mM of MgCl2. 
Consistently with previous reported hypothesis, the high dependence of DEFL 13 
antifungal activity on the cation composition of the medium suggests that the interaction 
between DEFL 13 and fungal membrane is mainly caused by electrostatic interaction with 
negative charged structures of fungal membranes. For this reason, the reported specificity 
of action for DEFL 13 against B. cinerea could be associated with an intracellular target 
rather than a specific receptor on the fungal membrane. However, additional experiments 
are necessary to support this hypothesis. 
A significant variation in DEFL 13 antifungal activity has been also observed using 
different commercial PDB medium with different ionic composition. All together these 
data indicate that the antifungal potency of defensins in the presence of cations is important 
in order to evaluate the contribution of DEFL 13 in plant defense against pathogens. 
DEFL 13 displays a strong antifungal activity not only towards germinating conidia 
but also against the mycelium of B. cinerea, determining a significantly reduction of fungal 
biomass. Microscope observations reveal enlargement of vacuoles in fungal treated 
hyphae, indicating that vacuolation could be involved in antimicrobial activity of DEFL 
13. It was reported that toxic compounds produced by the antagonist action of Alternaria 
alternata in Plasmopara viticola cause drastic changes in fungal cell structure, such as 
abnormal vacuolation (Musetti R et al. 2006). The presence of enlarged vacuoles in fungal 
mycelium was reported to be a typical hallmark of programmed cell death by 
incompatibility (Pinan-Lucarrè B et al. 2005) and as effect of the presence of antagonist 
and/or toxic metabolites (Askary H et al. 1997). The tomato saponin α-tomatine induces 
cell death of Fusarium oxysporum through a programmed cell death together with a rapid 
generation of reactive oxygen species (ROS) in treated cells (Ito S et al. 2007). Among 
plant defensins, RsAFP2 and NaD1 induce ROS production in the human pathogen 
Candida albicans and in the filamentous fungi Fusarium oxysporium respectively (Aerts 
AM et al. 2007; van der Weerden et al. 2009).  
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DEFL 13 shows activity against B. cinerea protoplasts quantified as a percentage of 
growth inhibition slightly lower than the one shown against mycelium. In DEFL 13 
activity, the cell wall does not appear a crucial factor for its antifungal function, in contrast 
with NaD1 that drastically reduced its activity against F. oxysporum depleted to the cell 
wall (van der Weerden et al. 2010). Our results suggest a direct interaction between peptide 
and fungal membrane, not influenced by cell wall components. 
DEFL 13 is capable to induce strong membrane permeabilization in B. cinerea 
hyphae. Several defensins were also able to destabilize membranes (Thevissen K et al. 
1999), supporting the hypothesis that the membrane permeabilization is a common step for 
plant defensins antimicrobial activity. Further knowledge on the DEFL 13 antibotrytis 
action are necessary to identify the specific mechanism of action leading to membrane 
permeabilization. 
The interaction between fungi and FITC-labeled DEFL 13 was shown. After 1 h 
DEFL 13 already seems internalized in B. cinerea hyphae. Despite the membrane 
destabilization appears a common step for AMPs action, only few defensins were shown to 
be capable of entering the fungal cells. Similarly to DEFL 13, also PsD1 (a defensin from 
pea) and NaD1 localized inside the cells of sensitive fungi (Lobo DS et al. 2007; van der 
Weerden NL et al. 2008). For these two plant defensins additional mechanisms further 
than membrane destabilization contribute to the fungal death. Interaction with cyclin F and 
consequent affection of normal progression of cell cycle were necessary for PsD1 action, 
whereas ROS production was reported to occur in NaD1 treated fungi. It is possible that 
DEFL 13, upon internalization in B. cinerea cells, activates additional mechanisms 
responsible for fungal death.  
In order to identify a possible intracellular target in fungal cells, a library of B. 
cinerea signaling mutant has been screened. The screening of signaling B. cinerea mutants 
revealed that intracellular signaling cascades could be involved in the antimicrobial 
activity of DEFL 13 against B. cinerea. The mutants that were characterized by increased 
DEFL 13 tolerance as compared to wild type are depleted in genes encoding proteins with 
pleiotropic effects on the cell metabolism. For example, a mutant that is less susceptible to 
the peptide is depleted of the gene cdc42, encoding for a rho-type GTPase involved in cell 
cycle regulation, suggesting a possible effect of the peptide in cell cycle progression as 
previously reported by Lobo DS and co-workers for PsD1 (Lobo DS et al. 2007). 
Furthermore, the higher resistance to DEFL 13 action associated with the mutant Δbcgpr3 
(depleted to the gene encoding for a G protein-coupled receptor) could suggest a possible 
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contribute for this trans membrane receptor in antimicrobial peptides sensing. Consistently 
human α defensins were reported to interact with the G protein-coupled receptors (Yang D 
et al. 2000). 
The intracellular localization of DEFL 13 in treated B. cinerea cells and the different 
DEFL 13 antifungal activity against mutants affected in important cell regulation pathways 
could suggest that intracellular mechanisms are involved in DEFL 13 action.  
Site-direct mutagenesis of the γ-core motif was performed on DEFL 13 sequence. 
The γ-core motif (with a consensus sequence GXC(X3-9)C) is structurally composed by 
two anti-parallel β strands with an interposed loop that displays a net cationic charge. This 
motif is conserved among disulphide-containing antimicrobial peptides which target, 
interact, permeabilize, depolarize, activate receptors or interact with biomembranes. 
Previous works reported about the importance of γ-core motif for the antimicrobial action 
of plant defensins. Mutational analysis of RsAFP2 revealed that the amino acid residues 
important for antifungal activity clustered in two adjacent sites: one of this is between β-
strands 2 and 3, corresponding to the γ-core motif. Furthermore, studies about MsDef1 (a 
defensin from Medicago truncatula) indicate that the γ-core motif contains the major 
determinants for its antifungal activity.  
Both positive charged and hydrophobic residues of γ-core motif have been singularly 
mutated in DEFL 13 in order to obtain indications about possible crucial residues involved 
in peptide activity against B. cinerea. 
All tested DEFL 13 mutants induced SYOTX green fluorescence uptake by B. 
cinerea treated fungal hyphae suggesting that the selected residues are not crucial for 
membrane destabilization. Despite this test can not be considered a quantitative assay, the 
S48K mutation, determining an increase of net positive charge in the γ-core motif, shows 
higher level of fluorescence uptake, possibly associated with a stronger membrane 
permeabilization. This supports the hypothesis that electrostatic interactions are important 
for DEFL 13-membrane interaction, at least during the first step. On the other hand, the 
mutant L42S, displaying a decrease in hydrophobicity level, shows a weaker level of 
fluorescence uptake, suggesting that also hydrophobicity contributes to this interaction. 
Consistently, Sagaram et al. (Sagaram US et al. 2011) proposed that there is a correlation 
between net positive charge of the peptide and its antifungal activity but this could be 
affect by hydrobobic residues.  
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5.3.2.3 A model for DEFL 13 antibotrytis action 
Taken together data reported in this study provide several important indications on 
the function of DEFL 13 and allowed to draw a model on the possible mechanism of action 
of DEFL 13 (Figure 5.2). The model takes into consideration that DEFL 13 shows a fairly 
specific antifungal activity both against germinating conidia and actively growing 
mycelium of the fungal pathogen B. cinerea. Antifungal activity appears strongly inhibited 
by the presence of cations in the medium. DEFL 13 destabilizes and permeabilizes fungal 
membranes and enters fungal hyphae. Furthermore, the antibiotic action of DEFL 13 is 
displayed through activation of some signaling cascade components.  
Based on this model, DEFL 13 is electrostatically attracted to the negative charged 
lipids of the fungal membrane. After this, two possibilities are shown: 
(i) the peptide is internalized and activates some intracellular cascades causing 
membrane permabilization and fungal death 
(ii) the peptide causes membrane permeabilization and subsequently it is internalized  
Both the mechanisms take into account the involvement of intracellular cascades; these 
cause fungal death by a mechanism not yet identified, that could affect the cell cycle 
regulation. The intracellular mechanisms activated by DEFL 13 could be the basis of the 
DEFL 13 specificity. Further experiments should be performed to support the hypothesis 
that the molecular basis of DEFL 13 specificity are not associated with membrane 
interaction. 
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Figure 5.2 Model of action of DEFL 13 on B. cinerea treated hyphae. DEFL 13 is represented as NaD1 
three-dimensional structures and lightning in the fungal membranes indicate membrane destabilization. The 
two possibilities are shown: (i) the peptide is internalized and activates some intracellular cascades causing 
membrane permabilization and fungal death. (ii) the peptide causes membrane permeabilization and 
subsequently it is internalized. The intracellular pathways activated by DEFL 13 and leading to the fungal 
death have not been yet characterized. 
 
.  
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6 CONCLUSION REMARK 
Several months of this PhD have been invested in protein expression and purification 
of DEFL peptides. Availability of these peptides is of a crucial importance for the 
characterization of their antimicrobial activity in vitro and for any possible exploitation of 
these compounds as antimicrobial agents. For this reason, the development of a simple and 
short protocol is currently under investigation.  
The biological role of DEFL peptides in planta should be investigated also through 
quantification of the protein level, allowing a correlation between gene expression, 
antimicrobial activity in vitro and biological role. Furthermore, localization of DEFL 
peptides in vivo will be necessary to confirm a role for these peptides as defensins namely 
defense peptide acting extracellularly. Considering the strong cation sensitivity of DEFL 
13, the antimicrobial activity should be also tested at plant physiological condition. A 
further depth evaluation of all these DEFLs properties will allow to confirm the defense 
role in planta of studied DEFLs. 
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